Virtus Dividend, Interest & Premium Strategy Fund SC TO-I, filed Sep 1, 2026
Virtus Dividend, Interest & Premium Strategy Fund (NFJ)
As filed with the Securities and Exchange Commission September 1, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE TO
Tender Offer Statement under Section 14(d)(1) or 13(e)(1)
of the Securities Exchange Act of 1934
Virtus Dividend, Interest & Premium Strategy Fund
(Name of Subject Company (Issuer))
Virtus Dividend, Interest & Premium Strategy Fund
(Name of Filing Persons (Offeror))
Common Shares, Par Value $0.00001 Per Share
(Title of Class of Securities)
92840R101
(CUSIP Number of Class of Securities)
Kathryn L. Santoro
Vice President, Chief Legal Officer & Secretary for Registrant
One Financial Plaza
Hartford, CT 06103-2608
866-270-7788
(Name, address and telephone number of person authorized to receive notices and
communications on behalf of filing persons)
| ☐ | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
Check the appropriate boxes below to designate any transactions to which the statement relates:
| ☐ | third party tender offer subject to Rule 14d-1. |
| ☒ | issuer tender offer subject to Rule 13e-4. |
| ☐ | going-private transaction subject to Rule 13e-3. |
| ☐ | amendment to Schedule 13D under Rule 13d-2. |
Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐
If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:
| ☐ | Rule 13e-4(i) (Cross-Border Issuer Tender Offer) |
| ☐ | Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) |
INTRODUCTORY STATEMENT
| Item 1. | Summary Term Sheet. | |
| Reference is made to the Summary Term Sheet in the Issuer Tender Offer Statement that is attached hereto as Exhibit (a)(1)(i) and is hereby incorporated by reference. | ||
| Item 2. | Subject Company Information. | |
| (a) | The name of the issuer is Virtus Dividend, Interest & Premium Strategy Fund (the “Fund”). The Fund is a closed-end, diversified management investment company established as a business trust under the laws of the State of Massachusetts. The Fund’s address is 101 Munson Street, Greenfield, MA 01301-9683. The Fund’s telephone number is 866-270-7788. | |
| (b) | The title of the securities that are the subject of the Issuer Tender Offer Statement and the related Letter of Transmittal (the tender offer made thereby, the “Offer”) are the Fund’s issued and outstanding common shares, par value $0.00001 per share (the “Shares”). As of the close of business on July 31, 2026, there were 92,967,244 Shares issued and outstanding. Subject to the conditions set forth in the Offer, the Fund will purchase for cash up to 25% of its outstanding Shares, or up to 23,241,811 Shares based on the number of outstanding Shares as of July 31, 2026, that are properly tendered by holders of the Fund’s shares and not withdrawn as described in the Offer. | |
| (c) | The Shares are traded on the New York Stock Exchange (“NYSE”). Reference is made to Section 7 “NAV and Market Price Range of Shares” of the Issuer Tender Offer Statement, which is incorporated herein by reference. | |
| Item 3. | Identity and Background of Filing Person. | |
| (a) | The Fund is tendering for its own Shares. Please refer to Item 2(a) above for information required by this Item. Virtus Investment Advisers, LLC, the Adviser, serves as the investment adviser to the Fund. The Adviser is a Delaware limited liability company and a registered investment adviser under the Investment Advisers Act of 1940, as amended (the “Advisers Act”). The principal business address of the Adviser is One Financial Plaza, Hartford, CT 06103. The Adviser’s telephone number is 866-270-7788. NFJ Investment Group, LLC (“NFJ Group”) serves as investment sub-adviser to the equity and options portions of the Fund’s portfolio. NFJ Group is an affiliate of the Adviser and is organized as a Delaware limited liability company. NFJ Group is a registered investment adviser under the Advisers Act. The principal business address of NFJ Group is 2100 Ross Avenue, Suite 700, Dallas, TX 75201. NFJ Group’s telephone number is 214-754-1780. Voya Investment Management Co. LLC (“Voya”), serves as investment sub-adviser to the convertibles portion of the Fund’s portfolio. Voya is a limited liability company organized under the laws of Delaware and is a registered investment adviser under the Advisers Act. Voya is not affiliated with the Adviser, or NFJ Group. The principal business address of Voya is 200 Park Avenue, New York, NY 10166. Voya’s telephone number is 212-309-8200. The members of the Fund’s Board of Trustees (the “Board”) are Donald C. Burke, Sarah E. Cogan, F. Ford Drummond, Connie D. McDaniel, R. Keith Walton, Brian T. Zino, and George R. Aylward. The President and Principal Executive Officer of the Fund is George R. Aylward. The Chief Compliance Officer of the Fund is Timothy Branigan. The Treasurer and Principal Financial Officer of the Fund is W. Patrick Bradley. The Secretary of the Fund is Kathryn L. Santoro. The trustees and executive officers of the Fund may be reached at the Fund’s business address and phone number set forth in Item 2(a) above. | |
| (b) | Not applicable | |
| (c) | Not applicable | |
| Item 4. | Terms of the Transaction. | |
| (a)(1)(i) | Subject to the conditions in the Issuer Tender Offer Statement, the Fund will purchase up to 23,241,811 Shares that are properly tendered by shareholders by 5:00 p.m. Eastern Time on October 5, 2026, and not withdrawn as described in Item 4(a)(1)(vi). | |
| (a)(1)(ii) | The purchase price per Share tendered will be 99% of its net asset value (“NAV”) as of the close of regular trading on the NYSE on October 5, 2026 (or, if the Offer is extended, the expiration date as extended), upon the terms and conditions set forth in the Issuer Tender Offer Statement. Reference is made to the Cover Page, Section 2 “Acceptance for Payment and Payment for Shares” and Section 3 “Procedure for Tendering Shares” of the Issuer Offer Statement, which are incorporated herein by reference. | |
| (a)(1)(iii) | The Offer is scheduled to expire at 5:00 p.m. Eastern Time on October 5, 2026, unless extended. Reference is made to the Cover Page, Summary Term Sheet, Section 2 “Acceptance for Payment and Payment of Shares” and Section 4 “Rights of Withdrawal” of the Issuer Tender Offer Statement, which are incorporated herein by reference. | |
| (a)(1)(iv) | Not applicable | |
| (a)(1)(v) | Reference is made to the Cover Page, Summary Term Sheet, Section 1 “Terms of the Offer; Expiration Date”, Section 2 “Acceptance for Payment and Payment of Shares” and Section 4 “Rights of Withdrawal” of the Issuer Tender Offer Statement, which are incorporated herein by reference. | |
| (a)(1)(vi) | Reference is made to Section 1 “Terms of the Offer; Expiration Date” and Section 4 “Rights of Withdrawal” of the Issuer Tender Offer Statement, which are incorporated herein by reference. | |
| (a)(1)(vii) | Reference is made to Section 3 “Procedure for Tendering Shares” and Section 4 “Rights of Withdrawal” of the Issuer Tender Offer Statement, which is incorporated herein by reference. | |
| (a)(1)(viii) | Reference is made to Section 2 “Acceptance for Payment and Payment for Shares” of the Issuer Tender Offer Statement, which is incorporated herein by reference. | |
| (a)(1)(ix) | Reference is made to the Cover Page and Section 1 “Terms of the Offer; Expiration Date” of the Issuer Tender Offer Statement, which is incorporated herein by reference. | |
| (a)(1)(x) | Not applicable | |
| (a)(1)(xi) | Not applicable | |
| (a)(1)(xii) | Reference is made to Section 8 “Federal Income Tax Consequences of the Offer” of the Issuer Tender Offer Statement, which is incorporated herein by reference. | |
| (a)(1)(2) | Not applicable | |
| (a)(2) | Not applicable | |
| (b) | Any Shares to be purchased from any officer, trustee or affiliate of the Fund would be on the same terms and conditions as any other purchase of Shares. To the Fund’s knowledge, none of the officers, trustees, or affiliates of the Fund intends to tender Shares in the Offer. | |
| Item 5. | Past Contracts, Transactions, Negotiations and Agreements With Respect to the Issuer’s Securities. | |
| (a)-(d) | Not applicable | |
| (e) | Reference is made to Section 6 “Purpose of the Offer; Past Contracts or Arrangements” of the Issuer Tender Offer Statement, which is incorporated herein by reference. | |
| Item 6. | Purpose of This Tender Offer and Plans or Proposals. | |
| (a) – (c) | Reference is made to Section 6 “Purpose of the Offer; Past Contracts or Arrangements” of the Issuer Tender Offer Statement, which is incorporated herein by reference. | |
| Item 7. | Source and Amount of Funds or Other Consideration. | |
| (a) | Reference is made to Section 5 “Effect of the Offer; Source and Amount of Funds” of the Issuer Tender Offer Statement, which is incorporated herein by reference. | |
| (b) | There are no material conditions to the financing discussed in Item 7(a), above. | |
| (d) | The Fund has no plans at this time to borrow funds to purchase Shares tendered in connection with the Offer. | |
| Item 8. | Interest in Securities of the Subject Company. | |
| (a) | Reference is made to Section 10 “Interest of Trustees and Officers; Transactions and Arrangements Concerning the Shares” of the Issuer Tender Offer Statement, which is incorporated herein by reference. | |
| (b) | Neither the Fund nor, to the best of the Fund’s knowledge, any of the Fund’s trustees or executive officers, has effected any transaction in the Shares, other than for automatic dividend reinvestment, during the past 60 days except that on August 20, 2026, Ms. McDaniel purchased 350 shares of the Fund at a price of $15.67 per share in an open market transaction. | |
| Item 9. | Persons/Assets, Retained, Employed, Compensated or Used. | |
| (a) | No persons have been employed, retained, or are to be compensated by the Fund to make solicitations or recommendations in connection with the Offer. | |
| Item 10. | Financial Statements. | |
| Not applicable | ||
| Item 11. | Additional Information | |
| (a)(1) | None | |
| (a)(2) | None | |
| (a)(3) | Not applicable | |
| (a)(4) | Not applicable | |
| (a)(5) | None | |
| (c) | None | |
| Item 12. | Exhibits. | |
| (a)(1)(i) | Issuer tender offer statement dated September 1, 2026 | |
| (a)(1)(ii) | Form of letter of transmittal | |
| (a)(1)(iii) | Form of letter to brokers, dealers, commercial banks, trust companies, and other nominees. | |
| (a)(1)(iv) |
||
| (a)(1)(v) | Form of letter to shareholders | |
| (a)(2) | None | |
| (a)(3) | Not applicable | |
| (a)(4) | Not applicable | |
| (a)(5)(i) | Text of press release dated and issued April 17, 2026 | |
| (a)(5)(ii) | Notice of guaranteed delivery | |
| (b) | None | |
| (d)(1) | Standstill agreement by and among Virtus Investment Advisers, LLC, the Fund, and Saba Capital Management, L.P. dated April 17, 2026 | |
| (g) | None | |
| (h) | None | |
| 107 | Filing fee table | |
| Item 13. | Information Required by Schedule 13e-3 | |
| Not applicable | ||
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct.
| VIRTUS DIVIDEND, INTEREST & PREMIUM STRATEGY FUND | ||
| /s/ Kathryn L. Santoro | ||
| Name: Kathryn L. Santoro | ||
| Title: Secretary | ||
Dated: September 1, 2026
OFFER BY
VIRTUS DIVIDEND, INTEREST & PREMIUM STRATEGY FUND
TO PURCHASE FOR CASH
UP TO 25% OF ITS ISSUED AND OUTSTANDING COMMON SHARES
AT 99% OF NET ASSET VALUE PER SHARE
|
THE OFFER AND WITHDRAWAL RIGHT WILL EXPIRE AT 5:00 P.M. EASTERN TIME ON OCTOBER 5, 2026, UNLESS THE OFFER IS EXTENDED |
This Issuer Tender Offer Statement and the accompanying Letter of Transmittal (which together constitute the “Offer”) are not conditioned on any minimum number of outstanding common shares, par value $0.00001 per share (the “Shares”) being tendered but are subject to other conditions as outlined herein and in the Letter of Transmittal.
No person has been authorized to give any information or to make any representations in connection with the Offer other than those contained herein and in the Letter of Transmittal, and if given or made, such information or representations may not be relied upon as having been authorized by Virtus Dividend, Interest & Premium Strategy Fund (the “Fund”).
IMPORTANT
Any shareholder (“Shareholder”) desiring to tender any portion of his or her Shares of common shares of the Fund (“Common Shares”) should either (1) complete and sign the Letter of Transmittal in accordance with the instructions in the Letter of Transmittal, and mail or deliver the Letter of Transmittal with their certificates for the tendered Shares if such Shareholder has been issued physical certificates, signature guarantees for all Shareholders tendering uncertificated Shares, and any other required documents to Computershare Trust Company, N.A., the depositary for the Offer (the “Depositary”), or (2) request their broker, dealer, commercial bank, trust company or other nominee to effect the transaction for such Shareholder. Shareholders having Shares registered in the name of a broker, dealer, commercial bank, trust company or other nominee are urged to contact such broker, dealer, commercial bank, trust company or other nominee if they desire to tender Shares so registered.
Questions, requests for assistance and requests for additional copies of this Issuer Tender Offer Statement and the Letter of Transmittal may be directed to the Information Agent in the manner set forth on the last page of this Issuer Tender Offer Statement.
September 1, 2026
002CSR0AFD
TABLE OF CONTENTS
| Page | ||||||
| SUMMARY TERM SHEET |
1 | |||||
| INTRODUCTION |
5 | |||||
| 1. | Terms of the Offer; Expiration Date. | 5 | ||||
| 2. | Acceptance for Payment and Payment for Shares. | 6 | ||||
| 3. | Procedure for Tendering Shares. | 7 | ||||
| 4. | Rights of Withdrawal. | 9 | ||||
| 5. | Effect of the Offer; Source and Amount of Funds. | 9 | ||||
| 6. | Purpose of the Offer; Past Contracts or Agreements. | 11 | ||||
| 7. | NAV and Market Price Range of Shares. | 12 | ||||
| 8. | Federal Income Tax Consequences of the Offer. | 12 | ||||
| 9. | Certain Information Concerning the Fund, the Fund’s Adviser and the Fund’s Sub-Advisers. | 14 | ||||
| 10. | Interest of Trustees and Officers; Transactions and Arrangements Concerning the Shares. | 15 | ||||
| 11. | Certain Legal Matters; Regulatory Approvals. | 16 | ||||
| 12. | Certain Conditions of the Offer. | 16 | ||||
| 13. | Fees and Expenses. | 17 | ||||
| 14. | Miscellaneous. | 17 | ||||
| 15. | Contacting the Depositary and the Information Agent. | 17 | ||||
This Summary Term Sheet highlights certain information concerning this Issuer Tender Offer Statement and the accompanying Letter of Transmittal (which together constitute the “Offer”). To understand the Offer fully and for a more complete discussion of the terms and conditions of the Offer, you should carefully read the entire Issuer Tender Offer Statement and the related Letter of Transmittal.
| • | What is the Offer? |
Virtus Dividend, Interest & Premium Strategy Fund (the “Fund”) is offering to purchase up to 25% of its outstanding common shares, par value $0.00001 per share (the “Shares”), or 23,241,811 Shares, for cash at a price per Share equal to 99% of the net asset value per Share (the “NAV”) as of the close of regular trading on the New York Stock Exchange (“NYSE”) on October 5, 2026 or, if the Offer is extended, the expiration date as extended (the “Expiration Date”), upon specified terms and subject to conditions as set forth in the Offer documents.
| • | When will the Offer expire, and may the Offer be extended? |
The Offer will expire at 5:00 p.m. Eastern Time on October 5, 2026, unless extended. The Fund may extend the period of time the Offer will be open by issuing a press release or making a public announcement no later than 9:00 a.m. Eastern Time on the business day after the Offer otherwise would have expired. For more information see Section 1 of the Issuer Tender Offer Statement.
| • | What is the NAV and Market Price as of a recent date? |
As of July 31, 2026 the NAV per Share was $16.40. For more information see Section 7 of the Issuer Tender Offer Statement for details. During the pendency of the Offer, current NAV quotations can be obtained from Georgeson LLC (“Georgeson”), the Fund’s information agent, by calling toll free 866-989-3459 between 9:00 a.m. and 11:00 p.m. Eastern Time, Monday through Friday, or by calling the Fund toll free at 866-270-7788 between 8:30 a.m. and 6:00 p.m. Eastern Time, Monday through Thursday, and 8:30 a.m. and 5:00 p.m. Eastern Time Friday (except holidays).
Also as of July 31, 2026, the market price per Share was $15.22, which is 92.8% of the NAV per Share and represents a -7.20% discount to the NAV. As with the Fund’s NAV, it is not possible to predict the market price per Share at a future date, including on the Expiration Date. On the Expiration Date, it is possible that the discount to NAV of the market price may be less than the 1% discount to NAV of the purchase price pursuant to the Offer. It is also possible that on the Expiration Date, the market price may be more than the NAV such that the Fund is trading at a “premium” to the NAV.
| • | Will the NAV be higher or lower on the date that the price to be paid for tendered Shares is to be determined? |
It is not possible to accurately predict the NAV at a future date.
| • | How do I tender my Shares? |
If your Shares are registered in your name, obtain and read the Offer materials carefully and if you decide to tender your Shares, properly complete and submit the Letter of Transmittal and any other documents required by the Letter of Transmittal. In addition, either the certificate for Shares must be transmitted to and received by Computershare (the “Depositary”) at one of its addresses set forth on the last page of this Offer, or you must comply with the Book Entry Delivery Procedure. For more information see Section 3 of the Issuer Tender Offer Statement. These materials must be received by Computershare Trust Company, N.A., the Fund’s Depositary, in proper form before 5:00 p.m. Eastern Time on the Expiration Date. You may also comply with the Guaranteed Delivery Procedure, see Section 3 of the Issuer Tender Offer Statement. If your Shares are held by a broker, dealer, commercial bank, trust company or other nominee (i.e., in “street name”), you should contact that firm to obtain and read the package of information necessary to make your decision. If you decide to tender your Shares, you must direct that firm to complete, compile and deliver the necessary documents for submission to the Depositary by 5:00 p.m. Eastern Time on the Expiration Date.
1
Please note that the Fund no longer issues certificated shares. If you remain in possession of certificated shares of the Fund that have not been surrendered and you elect to participate in the Offer, you are required to surrender such shares to the Fund in exchange for uncertificated shares. Uncertificated shares are reflected only in the Fund’s record books and are not represented by physical certificates. If you have questions regarding your certificated shares or have questions regarding the surrender and exchange process, please call the Fund toll free at 866-270-7788 for further instructions.
For more information see Section 3 of the Issuer Tender Offer Statement.
| • | Is there any cost to me to tender? |
No fees or commission will be payable to the Fund in connection with the Offer. However, brokers, dealers or other persons may charge you a fee for soliciting tenders for Shares pursuant to the Offer. You may be obligated to pay transfer taxes on the purchase of Shares by the Fund and other transaction costs. Please contact the Fund at 866-270-7788 for more information.
| • | May I withdraw my Shares after I have tendered them and, if so, by when? |
Yes, you may withdraw your Shares at any time prior to 5:00 p.m. Eastern Time on the Expiration Date.
Withdrawn Shares may be re-tendered by following the tender procedures before the Expiration Date. For more information see Section 4 of the Issuer Tender Offer Statement.
| • | How do I withdraw tendered Shares? |
A notice of withdrawal of tendered Shares must be timely received by the Depositary (as described in the previous paragraph), which specifies the name of the Shareholder who tendered the Shares and the number of Shares being withdrawn (which must be all of the Shares tendered) and, as regards Share certificates which represent tendered Shares that have been delivered or otherwise identified to the Depositary, the name of the registered owner of such Shares if different than the person who tendered the Shares. The notice of withdrawal, and all other required documents, must be received by the Depositary prior to 5:00 p.m. Eastern Time on the Expiration Date. See Section 4 of the Issuer Tender Offer Statement.
| • | May I place any conditions on my tender of Shares? |
No.
| • | Is there a maximum number of Shares that I may tender? |
No, however, the Fund will accept for payment, and will pay for, up to 25% of the Fund’s outstanding Shares. For more information see Section 1 of the Issuer Tender Offer Statement.
| • | What if, in the aggregate, more than 23,241,811 Shares are tendered? |
The Fund will purchase duly tendered Shares from tendering Shareholders pursuant to the terms and conditions of the Offer on a pro rata basis (disregarding fractions) in accordance with the number of Shares tendered by each Shareholder (and not timely withdrawn), unless the Fund determines not to purchase any Shares as described in Section 12 of the Issuer Tender Offer Statement. This tender offer will not have any special pro ration provision for odd-lot tenders, which means that all odd-lot tenders (including Shareholders who own fewer than 100 Shares) are subject to proration. The Fund’s present intention, if the Offer is oversubscribed, is not to purchase more than 23,241,811 Shares. For more information see Section 1 of the Issuer Tender Offer Statement.
| • | If I decide not to tender, how will the Offer affect the Fund Shares I hold? |
If you decide not to tender, your percentage ownership interest in the Fund will increase after completion of the Offer.
2
| • | What if I participate in the Fund’s Automatic Reinvestment and Cash Purchase Plan? |
The Depositary holds Shares in uncertificated form for certain Shareholders pursuant to the Fund’s Automatic Reinvestment and Cash Purchase Plan (the “Plan”). Shareholders may tender such uncertificated Shares by completing the appropriate section of the Letter of Transmittal or Notice of Guaranteed Delivery. A Shareholder who participates in the Plan and elects to tender all Shares will terminate their participation in the Plan pursuant to the terms of the Plan. If a Shareholder’s tender is not accepted in full due to the tender being prorated, and the Shareholder continues to hold Shares after the Expiration Date, the Shareholder may re-enroll in the Plan at any time by notifying the Depositary online at www.computershare.com/investor, by writing to the Depositary at P.O. Box 43078, Providence, RI 02940-3078, or by calling 866-270-7788.
| • | Does the Fund have the financial resources to pay for the tendered Shares? |
Yes. Although permitted to do so, the Fund does not expect to borrow money to finance the purchase of any tendered Shares. For more information see Section 5 of the Issuer Tender Offer Statement.
| • | If Shares I tender are accepted by the Fund, when will payment be made? |
It is contemplated, subject to change, that payment for tendered Shares, if accepted, will be made on or about October 13, 2026 for Shareholders holding Shares through a broker, dealer, commercial bank, trust company or other nominee, and October 13, 2026 for Shareholders holding Shares directly.
| • | Is my sale of Shares in the Offer a taxable transaction? |
All U.S. Shareholders, other than those who are tax exempt, who sell Shares in the Offer will generally recognize a gain or loss for U.S. federal income tax purposes equal to the difference between the cash they receive for the Shares sold and their adjusted basis in the Shares. The sale date for tax purposes will be the date the Fund accepts Shares for purchase. For more information see Section 8 of the Issuer Tender Offer Statement for details, including the nature of the income or loss and the differing rules for U.S. and non-U.S. Shareholders.
The Fund and its affiliates do not provide tax advice. Please consult your own tax adviser when deciding whether to participate in the Offer.
| • | Is the Fund required to complete the Offer and purchase all Shares tendered up to the number of Shares tendered for? |
Under most circumstances, yes. There are certain circumstances, however, in which the Fund will not be required to purchase any Shares tendered as described in Section 12 of the Issuer Tender Offer Statement.
| • | Is there any reason Shares tendered would not be accepted? |
In addition to those circumstances described in Section 12 of the Issuer Tender Offer Statement in which the Fund is not required to accept tendered Shares, the Fund has reserved the right to reject any and all tenders determined by it to not be in good order. For example, tenders will be rejected if the tender does not include the original signature(s) or the original of any required signature guarantee(s).
| • | How will tendered Shares be accepted for payment? |
Properly tendered Shares will be accepted for payment by a determination of the Fund, followed by notice of acceptance to the Depositary. The Depositary will thereafter make payment as directed by the Fund with monies deposited with it by the Fund. For more information see Section 2 of the Issuer Tender Offer Statement.
| • | What action need I take if I decide not to tender my Shares? |
None.
3
| • | Does management encourage Shareholders to participate in the Offer, and will they participate in the Offer? |
No. The Fund, its Board of Trustees, and the Fund’s investment adviser, Virtus Investment Advisers, LLC, and the Fund’s investment sub-advisers, NFJ Investment Group, LLC and Voya Investment Management Co. LLC, are not making any recommendation to tender or not to tender Shares in the Offer. “Affiliated persons” of the Fund, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), including trustees and officers of the Fund, may be prohibited by the 1940 Act from participating in the Offer. None of the members of the Fund’s Board of Trustees, the executive officers of the Fund, the Fund’s investment adviser or the Fund’s investment sub-advisers intend to participate in the Offer.
| • | How do I obtain additional information? |
Questions and requests for assistance should be directed to Georgeson toll free at 866-989-3459. Requests for additional copies of the Issuer Tender Offer Statement, the Letter of Transmittal and all other Offer documents should also be directed to Georgeson toll free at 866-989-3459. If you do not own Shares directly, you may obtain this information and the documents from your broker, dealer, commercial bank, trust company or other nominee, as appropriate.
4
To the Shareholders of Common Shares
Virtus Dividend, Interest & Premium Strategy Fund
Virtus Dividend, Interest & Premium Strategy Fund (the “Fund”), a Massachusetts business trust registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as a closed-end, diversified management investment company, hereby offers to purchase up to 25% of the Fund’s outstanding shares of common stock, or 23,241,811 shares in the aggregate (the “Offer Amount”), par value $0.00001 per share (the “Shares”), at a price, net to the seller in cash, equal to 99% of the net asset value (“NAV”) per Share in U.S. dollars (the “Purchase Price”) as of the close of regular trading on the New York Stock Exchange (“NYSE”) on October 5, 2026 or, if the Offer is extended, the expiration date as extended (the “Expiration Date”), upon the terms and subject to the conditions set forth in this Issuer Tender Offer Statement and in the related Letter of Transmittal (which together constitute the “Offer”). The Fund’s depositary for the Offer is Computershare Trust Company, N.A. (the “Depositary”) and the information agent is Georgeson LLC (“Georgeson”). The Fund mailed the Offer materials to Shareholders of record on or about September 1, 2026.
The Offer is extended to all shareholders of the Fund (“Shareholders”) and is not conditioned on any minimum number of Shares tendered but is subject to other conditions as outlined herein and in the Letter of Transmittal.
No person has been authorized to give any information or to make any representations in connection with the Offer other than those contained herein and in the Letter of Transmittal, and if given or made, such information or representations may not be relied upon as having been authorized by the Fund. “Affiliated persons” of the Fund, as defined in the 1940 Act, including trustees and officers of the Fund, may be prohibited by the 1940 Act from participating in the Offer. None of the members of the Fund’s Board of Trustees (the “Board”), the executive officers of the Fund, the Fund’s investment adviser, Virtus Investment Advisers, LLC (the “Adviser”) or the Fund’s investment sub-advisers, NFJ Investment Group, LLC (“NFJ Group”) and Voya Investment Management Co. LLC (“Voya” and together with NFJ Group, the “Sub-Advisers”), intend to participate in the Offer.
As of July 31, 2026, there were 92,967,244 Shares issued and outstanding and the NAV per Share was $16.40. The Fund does not expect that the number of Shares issued and outstanding will be materially different on the Expiration Date. Shareholders may contact Georgeson toll free at 866-989-3459 or the Fund directly at 866-270-7788 to obtain current NAV quotations for the Shares.
Also as of July 31, 2026, the market price per Share was $15.22, which is 92.8% of the NAV per Share and represents a -7.20% discount to the NAV. As with the Fund’s NAV, it is not possible to predict the market price per Share at a future date, including on the Expiration Date. On the Expiration Date, it is possible that the discount to NAV of the market price may be less than the 1% discount to NAV of the Purchase Price pursuant to the Offer. It is also possible that on the Expiration Date, the market price may be more than the NAV such that the Fund is trading at a “premium” to the NAV.
Any Shares acquired by the Fund pursuant to the Offer will be cancelled and retired. Tendering Shareholders may be obligated to pay brokerage fees or commissions or transfer taxes on the purchase of Shares by the Fund. Shareholders may also be subject to other transaction costs, as described in Section 1.
| 1. | Terms of the Offer; Expiration Date. |
Upon the terms and subject to the conditions set forth in the Offer, the Fund will accept for payment, and will pay for, up to 25% of the Fund’s outstanding Shares validly tendered on or prior to 5:00 p.m. Eastern Time on the Expiration Date and not withdrawn as described in Section 4. The Purchase Price of the Shares will equal 99% of the NAV of the Fund’s Shares (a 1% discount) as of the close of regular trading on the NYSE on the Expiration Date.
5
If the number of Shares properly tendered and not withdrawn prior to the Expiration Date is less than or equal to the Offer Amount, the Fund will, upon the terms and conditions of the Offer, purchase all Shares so tendered. If, in the aggregate, more than 23,241,811 Shares are properly tendered pursuant to the Offer (and not withdrawn as provided in Section 4), unless the Fund determines not to purchase any Shares, the Fund will purchase Shares from tendering Shareholders in accordance with the terms and conditions specified in the Offer on a pro rata basis (disregarding fractions) based on the number of Shares properly tendered by or on behalf of each Shareholder. This tender offer will not have any special pro ration provision for odd-lot tenders, which means that all odd-lot tenders (including Shareholders who own fewer than 100 Shares) are subject to proration. The Fund does not contemplate extending the Offer and increasing the number of Shares covered thereby if more than 23,241,811 Shares are properly tendered.
The Fund expressly reserves the right, in its sole discretion, at any time or from time to time, to extend the period of time during which the Offer is open by giving oral or written notice of such extension to the Depositary. Any such extension will also be publicly announced by press release issued no later than 9:00 a.m. Eastern Time on the next business day after the previously scheduled Expiration Date. If the Fund makes a material change in the terms of the Offer or the information concerning the Offer, or if it waives a material condition of the Offer, the Fund will extend the Offer to the extent required by Rules 13e-4(d)(2) and 13e-4(e)(3) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). During any extension, all Shares previously tendered and not withdrawn will remain subject to the Offer, subject to the right of a tendering Shareholder to withdraw their Shares.
Subject to the terms and conditions of the Offer, the Fund will pay the consideration offered or return the tendered Shares promptly after the termination or withdrawal of the Offer. Any extension, delay, termination or amendment will be followed as promptly as practicable by a public announcement thereof. In the case of an extension, such announcement will be issued no later than 9:00 a.m. Eastern Time on the business day immediately following the previously scheduled Expiration Date.
| 2. | Acceptance for Payment and Payment for Shares. |
Upon the terms and subject to the conditions of the Offer, the Fund will accept for payment, and will pay for, as soon as practicable after the Expiration Date, Shares validly tendered on or before the Expiration Date and not properly withdrawn in accordance with Section 4. In all cases, payment for Shares tendered and accepted for payment pursuant to the Offer will be made only after timely receipt by the Depositary of certificates for such Shares (unless such Shares are held in uncertificated form), a properly completed and duly executed Letter of Transmittal and any other documents required by the Letter of Transmittal. The Fund expressly reserves the right, in its sole discretion, to delay the acceptance for payment of, and/or the payment for, Shares to comply, in whole or in part, with any applicable law.
For purposes of the Offer, the Fund will be deemed to have accepted for payment Shares validly tendered and not withdrawn as provided in Section 4, if and when the Fund gives oral or written notice to the Depositary of its acceptance for payment of such Shares pursuant to the Offer. Payment for Shares accepted for payment pursuant to the Offer will be made by the Fund depositing the aggregate purchase price therefor with the Depositary. The Depositary will serve as agent for the tendering Shareholders for the purpose of receiving payments from the Fund and transmitting such payments to the tendering Shareholders. Under no circumstances will interest on the Purchase Price for Shares be paid, regardless of any delay in making such payment.
If any tendered Shares are not accepted for payment pursuant to the terms and conditions of the Offer for any reason, or are not paid because of an invalid tender, or if certificates are submitted for more Shares than are tendered (i) such unpurchased Shares will be returned in uncertificated form, without expense to the tendering Shareholder, as soon as practicable following expiration or termination of the Offer, (ii) Shares delivered pursuant to the Book-Entry Delivery Procedure (as defined in Section 3 below) will be credited to the appropriate
6
account maintained within the appropriate Book-Entry Transfer Facility, and (iii) uncertificated Shares held by the Fund’s transfer agent pursuant to the Fund’s Book-Entry and Automatic Reinvestment and Cash Purchase Plan will be returned to each account maintained by the transfer agent.
If the Fund is delayed in its acceptance for payment of, or in its payment for, Shares, or is unable to accept for payment or pay for Shares pursuant to the Offer for any reason, then, without prejudice to the Fund’s rights under the Offer, the Depositary may, on behalf of the Fund, retain tendered Shares, and such Shares may not be withdrawn unless and except to the extent tendering Shareholders are entitled to withdrawal rights as described in Section 4.
Tendering Shareholders may be obliged to pay brokerage commissions or fees and transfer taxes under certain circumstances. Please contact the Fund at 866-270-7788 for more information.
The Fund’s Shares are listed on the NYSE and the Fund normally calculates the Shares’ NAV daily at the close of regular trading on the NYSE. On July 31, 2026, the NAV was $16.40 and the last sales price at the close of regular trading on the NYSE was $15.22 per Share. The NAV of the Fund’s Shares will be available daily through the Expiration Date by calling the Fund’s Information Agent toll free at 866-989-3459 or by calling the Fund toll free at 866-270-7788.
| 3. | Procedure for Tendering Shares. |
Shareholders having Shares that are registered in the name of a broker, dealer, commercial bank, trust company or other nominee should contact such firm if they desire to tender their Shares. For a Shareholder to validly tender Shares pursuant to the Offer: (a)(i) a properly completed and duly executed Letter of Transmittal, together with any required signature guarantees and any other documents required by the Letter of Transmittal, must be transmitted to and received by the Depositary at one of its addresses set forth on the last page of the Offer, and (ii) either the certificate for Shares must be transmitted to and received by the Depositary at one of its addresses set forth on the last page of this Offer, or the tendering Shareholder must comply with the Book-Entry Delivery Procedure set forth in this Section 3, or (b) Shareholders must comply with the Guaranteed Delivery Procedure set forth in this Section 3, in all cases prior to the Expiration Date.
The Depositary holds Shares in uncertificated form for certain Shareholders pursuant to the Fund’s Automatic Reinvestment and Cash Purchase Plan (the “Plan”). Shareholders may tender such uncertificated Shares by completing the appropriate section of the Letter of Transmittal or Notice of Guaranteed Delivery. A Shareholder who participates in the Plan and elects to tender all Shares will terminate their participation in the Plan pursuant to the terms of the Plan. If the Shareholder’s tender is not accepted in full due to the tender being prorated and the Shareholder continues to hold Shares after the Expiration Date, the Shareholder may re-enroll in the Plan at any time by notifying the Depositary online at www.computershare.com/investor, by writing to the Depositary at P.O. Box 43078, Providence, RI 02940-3078, or by calling 866-270-7788.
The Fund no longer issues certificated shares. If you remain in possession of certificated shares of the Fund that have not been surrendered and you elect to participate in the Offer, you are required to surrender such shares to the Fund in exchange for uncertificated shares. Uncertificated shares are reflected only in the Fund’s record books and are not represented by physical certificates. If you have questions regarding your certificated shares or have questions regarding the surrender and exchange process, please call the Fund toll free at 866-270-7788 for further instructions.
Signatures on Letters of Transmittal must be guaranteed by a member firm of a registered national securities exchange or of the Financial Industry Regulatory Authority, or by a commercial bank or trust company having an office, branch or agency in the United States (each an “Eligible Institution”) unless (i) the Letter of Transmittal is signed by the registered holder of the Shares tendered, including those Shareholders who are participants in a Book-Entry Transfer Facility and whose name appears on a security position listing as the owner of the Shares, but excluding those registered Shareholders who have completed either the “Special Payment
7
Instructions” box or the “Special Delivery Instructions” box on the Letter of Transmittal, or (ii) such Shares are tendered for the account of an Eligible Institution. In all other cases, all signatures on the Letter of Transmittal must be guaranteed by an Eligible Institution. For more information see the instructions to the Letter of Transmittal.
Shareholders should read and follow the instructions on the Letter of Transmittal to ensure that the document is properly completed and all required signatures and authorizations are obtained prior to submitting the document to the Depositary. For more information see the instructions to the Letter of Transmittal.
To prevent U.S. backup withholding tax on payments made for the purchase of Shares purchased pursuant to the Offer, a Shareholder who does not otherwise establish an exemption from such backup withholding must provide the Depositary with his or her correct taxpayer identification number and certify that he is not subject to backup withholding by completing the Form W-9 included with the Letter of Transmittal.
Foreign Shareholders who have not previously submitted an applicable Form W-8 to the Fund must do so to avoid backup withholding. The Fund may withhold 30% of the proceeds otherwise payable to a foreign Shareholder. For more information see Section 8, below.
All questions as to the validity, form, eligibility (including time of receipt), payment and acceptance for payment of any tender of Shares will be determined by the Fund, in its sole discretion, which determination shall be final and binding. The Fund reserves the absolute right to reject any and all tenders of Shares it determines not to be in good order or the acceptance for payment of which may, in the opinion of its counsel, be unlawful. The Fund also reserves the absolute right to waive any of the conditions of the Offer or any defect or irregularity in the tender of any Shares. No tender of Shares will be deemed to have been validly made until all defects and irregularities have been cured or waived. Neither the Fund, the Adviser, the Information Agent, the Depositary, nor any other person shall be under any duty to give notification of any defects or irregularities in tenders, nor shall any of the foregoing incur any liability for failure to give any such notification. The Fund’s interpretation of the terms and conditions of the Offer (including the Letter of Transmittal and instructions thereto) will be final and binding.
Payment for Shares tendered and accepted for payment pursuant to the Offer will be made, in all cases, only after timely receipt of (i) certificates for such Shares by the Depositary or book-entry confirmation of delivery of such Shares to the account of the Depositary, (ii) a properly completed and duly executed Letter of Transmittal for such Shares, and (iii) any other documents required by the Letter of Transmittal. The tender of Shares pursuant to any of the procedures described in this Section 3 will constitute an agreement between the tendering Shareholder and the Fund upon the terms and subject to the conditions of the Offer.
The method of delivery of all required documents is at the election and risk of each tendering Shareholder. If delivery is to be by mail, then registered mail with return receipt requested, properly insured, is recommended.
Book-Entry Delivery Procedure
The Depositary will establish accounts with respect to the Shares at the Depository Trust Company (the “Book-Entry Transfer Facility”) for purposes of the Offer within a week after the date of the Offer. Any financial institution that is a participant in any of the Book-Entry Transfer Facility’s systems may make delivery of tendered Shares by (i) causing such Book-Entry Transfer Facility to transfer such Shares into the Depositary’s account in accordance with such Book-Entry Transfer Facility’s procedure for such transfer, and (ii) causing a confirmation of receipt of such delivery to be received by the Depositary (the “Book-Entry Delivery Procedure”). The Book-Entry Transfer Facility may charge the account of such financial institution for tendering Shares on behalf of Shareholders. Notwithstanding that delivery of Shares may be properly effected in accordance with this Book-Entry Delivery Procedure, the Letter of Transmittal, with signature guarantee, if required, and all other documents required by the Letter of Transmittal must be transmitted to and received by the Depositary at the
8
appropriate address set forth on the last page of the Offer on or before the Expiration Date, or the tendering Shareholder must comply with the Guaranteed Delivery Procedure set forth below. Delivery of the Letter of Transmittal and any other required documents to a Book-Entry Transfer Facility in accordance with such Book-Entry Transfer Facility’s procedures does not constitute delivery to the Depositary for purposes of the Offer.
Guaranteed Delivery Procedure
If Shares are not immediately available or the Letter of Transmittal and other required documents are unable to reach the Depositary in a timely manner prior to the Expiration Date, Shares nevertheless may be deemed to be properly tendered provided that (i) such tenders are made by or through a member firm of a registered national securities exchange or of the Financial Industry Regulatory Authority, or by a commercial bank or trust company having an office, branch or agency in the United States (each an “Eligible Institution”), (ii) the Depositary receives, prior to the Expiration Date, a properly completed and duly executed Notice of Guaranteed Delivery substantially in the form provided by the Fund (delivered by mail or email), and (iii) confirmation of the delivery of Shares delivered into the Depositary’s account in accordance with the Book-Entry Transfer Facility’s procedure for such transfer, together with a properly completed and duly executed Letter of Transmittal and any other documents required by the Letter of Transmittal, are received by the Depositary within one business day after the Expiration Date.
| 4. | Rights of Withdrawal. |
Tenders of Shares made pursuant to the Offer may be withdrawn at any time prior to the Expiration Date. After the Expiration Date, all tenders made pursuant to the Offer are irrevocable.
To be effective, a written notice of withdrawal must be timely received by the Depositary at one of its addresses set forth on the last page of the Offer. Any notice of withdrawal must specify the name of the person who executed the Letter of Transmittal or Notice of Guaranteed Delivery to be withdrawn, the number of Shares to be withdrawn (which must be all of the Shares tendered), and the names in which the Shares to be withdrawn are registered. Any signature on the notice of withdrawal must be guaranteed by an Eligible Institution. If certificates have been delivered to the Depositary, the name of the registered holder and the serial numbers of the particular certificates evidencing the Shares withdrawn must also be furnished to the Depositary. If Shares have been delivered pursuant to the Book-Entry Delivery Procedure set forth in Section 3, any notice of withdrawal must specify the name and number of the account at the appropriate Book-Entry Transfer Facility to be credited with the withdrawn Shares (which must be the same name, number, and Book-Entry Transfer Facility from which the Shares were tendered), and must comply with the procedures of that Book-Entry Transfer Facility.
All questions as to the form and validity, including time of receipt, of any notice of withdrawal will be determined by the Fund, in its sole discretion, which determination shall be final and binding. Neither the Fund, the Fund’s Adviser, the Information Agent, the Depositary, nor any other person shall be under any duty to give notification of any defects or irregularities in any notice of withdrawal, nor shall any of the foregoing incur any liability for failure to give such notification. Any Shares properly withdrawn will be deemed not to have been validly tendered for purposes of the Offer. However, withdrawn Shares may be re-tendered by following the procedures described in Section 3 at any time prior to the Expiration Date.
If the Fund is delayed in its acceptance for payment of Shares, or is unable to accept for payment Shares tendered pursuant to the Offer, for any reason, then without prejudice to the Fund’s rights under the Offer the Depositary may, on behalf of the Fund, retain tendered Shares, and such Shares may not be withdrawn except to the extent that tendering Shareholders are entitled to withdrawal rights as set forth in this Section 4.
| 5. | Effect of the Offer; Source and Amount of Funds. |
The actual cost of the Offer to the Fund cannot be determined at this time because the number of Shares to be purchased will depend on the number tendered, and the price to be paid will be based on the NAV per Share
9
on the Expiration Date. If the NAV per Share on the Expiration Date were the same as the NAV per Share on July 31, 2026, and if Shareholders tender 25% of the Fund’s outstanding Shares, the estimated payments by the Fund to Shareholders would be approximately $377,354,043.40. This is based on a price per Share of 16.24, which is 99% of the Fund’s NAV as determined on July 31, 2026. Please refer to the pro forma capitalization table below for additional information.
The Fund intends to purchase Shares using cash and by selling securities in the Fund’s investment portfolio to raise cash. Although permitted to do so, the Fund does not expect to borrow money to finance the purchase of any tendered Shares.
The Offer may have certain adverse consequences for tendering and non-tendering Shareholders.
Effect on NAV and Consideration Received by Tendering Shareholders. If the Fund is required to sell a substantial amount of portfolio securities to raise cash to finance the Offer, the market prices of the Fund’s portfolio securities, and hence the Fund’s NAV, may decline. If such a decline occurs, the Fund cannot predict what its magnitude might be or whether such a decline would be temporary or continue to or beyond the Expiration Date. Because the price per Share to be paid in the Offer will be dependent upon the NAV as determined on the Expiration Date, if such a decline continued up to the Expiration Date, the consideration received by tendering Shareholders would be reduced. In addition, the sale of portfolio securities will cause the Fund to incur increased brokerage and related transaction expenses, and the Fund may receive proceeds from the sale of portfolio securities that are less than their valuations by the Fund. Accordingly, because of the Offer, the Fund’s NAV per Share may decline more than it otherwise might, thereby reducing the amount of proceeds received by tendering Shareholders and the value per Share for non-tendering Shareholders.
Shareholders should also note, however, that the Offer may result in accretion to the Fund’s NAV following the Offer due to the fact that the Purchase Price represents a 1% discount to the Fund’s NAV. The potential accretion to the Fund’s NAV may offset in whole or in part any decline in the Fund’s NAV as discussed above.
The Fund will likely sell portfolio securities during the pendency of the Offer to raise cash for the purchase of Shares. Thus, during the pendency of the Offer, and possibly for a short time thereafter, the Fund may hold a greater than normal percentage of its net assets in cash and cash equivalents. The Fund is required by law to pay for tendered Shares it accepts for payment promptly after the Expiration Date of the Offer. Because the Fund will not know the number of Shares tendered until the Expiration Date, the Fund will not know the amount of cash required to pay for such Shares until the Expiration Date. If on or prior to the Expiration Date the Fund does not have, or believes it is unlikely to have, sufficient cash to pay for all Shares tendered, it may extend the Offer to allow additional time to sell portfolio securities and raise sufficient cash.
Recognition of Capital Gains. As noted, the Fund will likely be required to sell portfolio securities pursuant to the Offer. If the Fund’s tax basis for the securities sold is less than the sale proceeds, the Fund will recognize capital gains. The Fund would expect to declare and distribute any such gains to Shareholders of record (reduced by net capital losses realized during the fiscal year, if any, and available capital loss carryforwards) during the calendar year. This recognition and distribution of gains, if any, would have two negative consequences: first, to raise cash to make the distributions, the Fund might need to sell additional portfolio securities, thereby possibly being forced to realize and recognize additional capital gains; and second, Shareholders at the time of a declaration of distributions would be required to pay taxes on a greater amount of capital gain distributions than otherwise would be the case. It is impossible to predict what the amount of unrealized gains or losses would be in the Fund’s portfolio at the time the Fund is required to liquidate portfolio securities (and hence the amount of capital gains or losses that would be realized and recognized). The Fund’s annual report for the period ended January 31, 2026 reflected net unrealized appreciation on a tax basis of $147,680,000 in the Fund’s portfolio as a whole.
10
In addition, some of the distributed gains may be realized on securities held for one year or less, which would generate income taxable to the Shareholders at ordinary income rates. This could adversely affect the Fund’s after-tax performance.
Tax Consequences of Repurchases to Shareholders. The Fund’s purchase of tendered Shares pursuant to the Offer will have tax consequences for tendering Shareholders and may have tax consequences for non-tendering Shareholders. For more information see Section 8, “Federal Income Tax Consequences of the Offer,” below.
Higher Expense Ratio and Less Investment Flexibility. If the Fund purchases a substantial number of Shares pursuant to the Offer, the net assets of the Fund would be reduced accordingly. The reduced net assets of the Fund that may result following the Offer could result in a higher expense ratio for the Fund, and possibly in less investment flexibility for the Fund, depending on the number of Shares repurchased.
Pro Forma Effects on Capitalization. The following table sets forth the net assets of the Fund as of July 31, 2026, adjusted to give effect to the Offer (excluding expenses and assuming the Fund repurchases 25% of its outstanding Shares):
PRO FORMA CAPITALIZATION(1)
| As of July 31, 2026 |
Adjustment for Purchase of 25% at $16.24 Per Share |
Pro Forma as Adjusted | ||||
| Total net assets |
$1,524,602,597 | $377,354,043.40 | $1,147,248,552.24 | |||
| Shares outstanding |
92,967,244 | 23,241,811 | 69,725,433 | |||
| NAV(3) |
$16.40 | $16.24(2) | $16.45 |
| (1) | This table assumes the Fund purchases 23,241,811 Shares, equal to 25% of the Fund’s outstanding Shares as of July 31, 2026. |
| (2) | This amount represents 99% of the Fund’s NAV as determined on July 31, 2026. Shares tendered pursuant to the Offer will be purchased at a 1% discount to NAV on the Expiration Date, which may be more or less than $16.24 per Share, and the pro forma NAV per Share also may be more or less. |
| (3) | The NAV per Share of the Fund is normally determined daily on each day that the NYSE is open, as of the close of regular trading on the NYSE and is determined by dividing the total net assets of the Fund by the number of Shares outstanding. |
| 6. | Purpose of the Offer; Past Contracts or Agreements. |
The Board has consistently recognized that it would be in the best interests of Shareholders to attempt to reduce or eliminate any discount at which the Fund’s Shares may trade to the NAV and the Board regularly considers potential discount mitigation actions during its board meetings. In connection with these considerations, the Board approved the Tender Offer (as defined below) on April 15, 2026, as recommended by the Fund’s Adviser as part of an effort to provide Shareholders with an alternative source of liquidity for their investment and to attempt to reduce the market discount at which the Fund’s Shares were then trading.
Additionally, the Board considered that the Adviser and the Fund were negotiating an agreement with Saba Capital Management, L.P, a Delaware limited partnership (“Saba”), pursuant to which Saba ultimately agreed, among other things, to refrain from activist activities with respect to the Fund through at least the 2027 annual meeting of the Fund’s shareholders, and the Adviser and Fund ultimately agreed, among other things, that the Adviser would recommend to the Board that the Fund conduct a tender offer for up to 25% of the Fund’s outstanding Shares at a price equal to 99% of the Fund’s NAV. After consideration and review, the Board found that the Tender Offer would be in the best interests of the Fund and its shareholders and approved the Tender Offer.
11
The Board has determined to effect the Offer under Rule 13e-4 of the Exchange Act. Any Shares acquired by the Fund pursuant to the Offer will be retired.
None of the Fund, its Board, the Adviser, or the Sub-Advisers makes any recommendation to any Shareholder as to whether to tender or refrain from tendering any Shares, and none of such persons has authorized any person to make any such recommendation. Shareholders are urged to evaluate carefully all information in the Offer, consult their own investment and tax advisers and make their own decisions whether to tender Shares.
Except to the extent described herein, the Fund has no present plans or proposals, and is not engaged in any negotiations, that relate to or would result in: any extraordinary corporate transaction, such as a merger, reorganization, or liquidation involving the Fund; any purchase, sale, or transfer of a material amount of assets of the Fund (other than in its ordinary course of business); any material changes in the Fund’s present capitalization (except as resulting from the Offer or otherwise set forth herein); or any other material changes in the Fund’s structure or business.
| 7. | NAV and Market Price Range of Shares. |
The Shares are traded on the NYSE. During the Fund’s fiscal quarters for the past two fiscal years, the high and low market price per Share during the fiscal quarter, and the market price per Share as of the close of ordinary trading on the NYSE and NAV as of the last business day of such fiscal quarter, were as follows:
| Market Price | ||||||||
| Fiscal Quarter Ended |
High | Low | Close | NAV | ||||
| July 31, 2024 |
$12.71 | $12.02 | $12.71 | $14.53 | ||||
| October 31, 2024 |
$13.08 | $12.00 | $12.59 | $14.40 | ||||
| January 31, 2025 |
$13.26 | $12.16 | $13.05 | $14.42 | ||||
| April 30, 2025 |
$12.94 | $10.60 | $11.63 | $13.12 | ||||
| July 31, 2025 |
$12.85 | $11.67 | $12.67 | $14.01 | ||||
| October 31, 2025 |
$13.22 | $12.48 | $12.86 | $14.58 | ||||
| January 31, 2026 |
$13.52 | $12.45 | $13.48 | $14.82 | ||||
| April 30, 2026 |
$14.19 | $12.35 | $14.19 | $15.42 | ||||
| July 31, 2026 |
$15.27 | $14.22 | $15.22 | $16.40 | ||||
During the pendency of the Offer, any distributions will be paid on the regularly scheduled distribution payment dates.
| 8. | Federal Income Tax Consequences of the Offer. |
The U.S. federal income tax discussion set forth below is a summary included for general information purposes only. In view of the individual nature of tax consequences, each Shareholder is advised to consult its own tax adviser with respect to the specific, individual tax consequences of participation in the Offer, including the effect and applicability of state, local, foreign and other tax laws and the possible effects of changes in federal or other tax laws.
The sale of Shares pursuant to the Offer will be a taxable transaction for U.S. federal income tax purposes, either as a “sale or exchange,” or under certain circumstances, as a “dividend.” Under Section 302(b) of the Internal Revenue Code of 1986, as amended (the “Code”), a sale of Shares pursuant to the Offer generally will be treated as a “sale or exchange” if the receipt of cash by the Shareholder: (a) results in a “complete termination” of the Shareholder’s interest in the Fund, (b) is “substantially disproportionate” with respect to the Shareholder, or (c) is “not essentially equivalent to a dividend” with respect to the Shareholder. In determining whether any of these tests has been met, Shares actually owned, as well as Shares considered to be owned by the Shareholder by reason of certain constructive ownership rules set forth in Section 318 of the Code, generally must be taken into
12
account. If any of these three tests for “sale or exchange” treatment is met, a Shareholder will recognize gain or loss equal to the difference between the price paid by the Fund for the Shares purchased in the Offer and the Shareholder’s adjusted basis in such Shares. If such Shares are held as a capital asset, the gain or loss will generally be capital gain or loss. The maximum tax rate applicable to net capital gains recognized by individuals and other non-corporate taxpayers is generally (i) the same as the applicable ordinary income rate for capital assets held for one year or less, or (ii) 15% or 20% (depending on whether the taxpayer’s income exceeds certain threshold amounts) for capital assets held for more than one year.
If the requirements of Section 302(b) of the Code are not met, amounts received by a Shareholder who sells Shares pursuant to the Offer will be taxable to the Shareholder as a “dividend” to the extent of such Shareholder’s allocable share of the Fund’s current or accumulated earnings and profits. To the extent that amounts received exceed such Shareholder’s allocable share of the Fund’s current and accumulated earnings and profits, such excess will constitute a non-taxable return of capital (to the extent of the Shareholder’s adjusted basis in its Shares), and any amounts in excess of the Shareholder’s adjusted basis will constitute taxable gain. Any remaining adjusted basis in the Shares tendered to the Fund will be transferred to any remaining Shares held by such Shareholder. In addition, if a tender of Shares is treated as a “dividend” to a tendering Shareholder, a constructive dividend under Section 305(c) of the Code may result to a non-tendering Shareholder whose proportionate interest in the earnings and assets of the Fund has been increased by such tender. The Fund believes that the nature of the repurchase will be such that the sale of Shares pursuant to the Offer will normally satisfy the test for a sale that is “not essentially equivalent to a dividend” and therefore will qualify for “sale or exchange” treatment (as opposed to “dividend” treatment).
Under the “wash sale” rules under the Code, provided the purchase of Shares pursuant to the Offer is treated as a sale or exchange (and not a distribution as described above), loss recognized on Shares repurchased pursuant to the Offer will ordinarily be disallowed to the extent the Shareholder acquires other shares of the Fund or substantially identical stock or securities within 30 days before or after such repurchase pursuant to the Offer and, in that event, the cost basis and holding period of the other shares acquired will be adjusted to reflect the disallowed loss.
An additional 3.8% Medicare tax is imposed on certain net investment income (including ordinary dividends and capital gain distributions received from the Fund and net gains from redemptions or other taxable dispositions of Shares) of U.S. individuals, estates and trusts to the extent that such person’s “modified adjusted gross income” (in the case of an individual) or “adjusted gross income” (in the case of an estate or trust) exceed certain threshold amounts. Shareholders should consult their tax advisors regarding the applicability of the Medicare tax to their sale of Shares pursuant to the Offer.
Foreign Shareholders. Any payments to a tendering Shareholder who is a nonresident alien individual, a foreign trust or estate or a foreign corporation (a “Foreign Shareholder”) that are treated as dividends for U.S. federal income tax purposes under the rules set forth above, will be subject to U.S. withholding tax at the rate of 30% (unless a reduced rate applies under an applicable tax treaty). A tendering Foreign Shareholder who realizes a capital gain on a tender of Shares will not be subject to U.S. federal income tax on such gain unless the Shareholder is an individual who is physically present in the United States for 183 days or more and certain other conditions exist. Such persons are advised to consult their own tax adviser. Special rules may apply in the case of Foreign Shareholders (i) that are engaged in a U.S. trade or business, (ii) that are former citizens or residents of the U.S., or (iii) that have a special status for U.S. federal tax purposes, such as “controlled foreign corporations,” “foreign personal holding companies,” corporations that accumulate earnings to avoid U.S. federal income tax, and certain foreign charitable organizations. Such persons are advised to consult their own tax adviser. The Fund may withhold 30% of the proceeds otherwise payable to a Foreign Shareholder. A Foreign Shareholder may be eligible to obtain a refund from the Internal Revenue Service of all or a portion of any tax withheld if such Foreign Shareholder satisfies certain requirements or is otherwise able to establish that no tax or a reduced amount of tax is due. Foreign Shareholders are urged to consult their own tax advisers regarding the application of federal income tax withholding, including eligibility for a withholding tax reduction or exemption, and the refund procedure.
13
Backup Withholding. The Fund generally will be required to withhold tax at the rate of 24% (“backup withholding”) from any payment to a tendering Shareholder that is an individual (or certain other non-corporate persons) if the Shareholder fails to provide to the Fund its correct taxpayer identification number or otherwise establish an exemption from the backup withholding tax rules. A foreign Shareholder generally will be able to avoid backup withholding with respect to payments by the Fund that are treated as made in exchange for tendered Shares only if it furnishes to the Fund a duly completed applicable Form W-8, signed under penalty of perjury, stating that it (1) is a nonresident alien individual or a foreign corporation, partnership, estate or trust, (2) has not been and does not plan to be present in the United States for a total of 183 days or more during the calendar year, and (3) is neither engaged, nor plans to be engaged during the year, in a United States trade or business that has effectively connected gains from transactions with a broker or barter exchange. Backup withholding is not an additional tax, and any amounts withheld may be credited against a Shareholder’s U.S. federal income tax liability.
FATCA. Under Sections 1471 to 1474 of the Code (such Sections commonly referred to as the Foreign Account Tax Compliance Act, or “FATCA”) and applicable U.S. Treasury regulations promulgated thereunder, U.S. federal withholding tax generally will be imposed at a rate of 30% on amounts treated as “dividends” paid to a tendering Shareholder that is a foreign financial institution or a non-financial foreign entity unless such foreign financial institution or non-financial foreign entity provides to the applicable withholding agent an applicable IRS Form W-8 demonstrating that FATCA withholding is not required. If the applicable withholding agent withholds tax under FATCA, it will not also withhold the 30% U.S. federal income tax described above. Foreign Shareholders are urged to consult their own tax advisors to determine the effect, if any, of FATCA on their participation in the Offer.
| 9. | Certain Information Concerning the Fund, the Fund’s Adviser and the Fund’s Sub-Advisers. |
The Fund is a closed-end, diversified management investment company organized as a Massachusetts business trust. The Shares were first issued to the public on February 23, 2005. As a closed-end management investment company, the Fund differs from an open-end investment company (i.e., a mutual fund) in that it does not redeem its Shares at the election of a Shareholder and does not continuously offer its Shares for sale to the public. The Fund’s investment objective is to seek current income and gains, with a secondary objective of long-term capital appreciation. NFJ Group manages the equity and options portions of the Fund’s portfolio. The equity portion of the Fund is generally invested in U.S. equities and American depositary receipts (ADRs) with attractive quality characteristics, shareholder yield, and consistent financial output. The options portion of the Fund is designed to generate gains from option premiums in an attempt to enhance amounts available for distributions payable to the Fund’s shareholders. Voya manages the convertible portion of the Fund and generally invests in income-producing convertible securities, including synthetic convertible securities, and may include convertible securities that are of below-investment grade quality.
The principal executive offices and business address of the Fund are located at 101 Munson Street, Greenfield, MA 01301-9683. The Fund’s business telephone number is 866-270-7788.
Virtus Investment Advisers, LLC, the Adviser, an indirect, wholly owned subsidiary of Virtus Investment Partners, Inc. (“Virtus”), serves as the investment adviser to the Fund. The Adviser is a Delaware limited liability company and a registered investment adviser under the Investment Advisers Act of 1940, as amended (the “Advisers Act”). The principal business address of the Adviser is One Financial Plaza, Hartford, CT 06103.
NFJ Group is an indirect, wholly owned subsidiary of Virtus and an affiliate of the Adviser. NFJ Group is a Delaware limited liability company and is a registered investment adviser under the Advisers Act. NFJ Group’s principal business address is 2100 Ross Avenue, Suite 700, Dallas, TX 75201.
Voya is a Delaware limited liability company and is a registered investment adviser under the Advisers Act. Voya’s principal business address is 200 Park Avenue, New York, NY 10166.
14
The Fund is subject to the information and reporting requirements of the 1940 Act and in accordance therewith is obligated to file reports and other information with the U.S. Securities and Exchange Commission (“SEC”) relating to its business, financial condition and other matters. The Fund has also filed an Issuer Tender Offer Statement on Schedule TO with the SEC. Such reports and other information should be available to the public, free of charge, on the SEC’s internet site (http://www.sec.gov). Copies may be obtained, by mail, upon payment of the SEC’s customary charges, by writing to its principal office at 100 F Street, N.E., Washington, D.C. 20549.
| 10. | Interest of Trustees and Officers; Transactions and Arrangements Concerning the Shares. |
The trustees and executive officers of the Fund and the aggregate number and percentage of the Shares each of them beneficially owned as of December 31, 2025, is set forth in the table below. The address of each of them is in care of the Fund at 101 Munson Street, Greenfield, MA 01301-9683.
| Name |
Position | Number of Shares Beneficially Owned |
Percentage of Shares Beneficially Owned | |||
| Donald C. Burke |
Independent Trustee | 1244 | 0.0013% | |||
| Sarah E. Cogan |
Independent Trustee | 1326 | 0.0014% | |||
| F. Ford Drummond |
Independent Trustee | 775 | 0.0008% | |||
| Connie D. McDaniel |
Independent Trustee | 427 | 0.0005% | |||
| R. Keith Walton |
Independent Trustee | — | — | |||
| Brian T. Zino |
Independent Trustee | 850 | 0.0009% | |||
| George R. Aylward |
Interested Trustee | 9180 | 0.0099% | |||
| Peter J. Batchelar |
Senior Vice President | — | — | |||
| W. Patrick Bradley |
Executive Vice President, Chief Financial Officer and Treasurer | — | — | |||
| Timothy Branigan |
Vice President and Fund Chief Compliance Officer | — | — | |||
| Kathryn Santoro |
Vice President, Chief Legal Officer, Counsel and Secretary | — | — | |||
| Julia Short |
Senior Vice President | — | — | |||
| Richard W. Smirl |
Executive Vice President | — | — | |||
| Nikita Thaker |
Vice President, Controller and Assistant Treasurer | — | — |
As of December 31, 2025, the trustees and executive officers of the Fund, as a group, beneficially owned less than 1% of the outstanding shares of the Fund.
Neither the Fund nor, to the best of the Fund’s knowledge, the Fund’s trustees or executive officers, or associates of any of the foregoing, has effected any transaction in the Shares, other than for automatic dividend reinvestment, during the past 60 days except that on August 20, 2026, Ms. McDaniel purchased 350 shares of the Fund at a price of $15.67 per share in an open market transaction.
Except as set forth in the Offer, neither the Fund, nor, to the best of the Fund’s knowledge, any of the Fund’s officers or trustees, is a party to any contract, arrangement, understanding or relationship with any other person relating, directly or indirectly, to the Offer with respect to any securities of the Fund, including, but not limited to, any contract, arrangement, understanding or relationship concerning the transfer or the voting of any such securities, joint ventures, loan or option arrangements, puts or calls, guaranties of loans, guaranties against loss or the giving or withholding of proxies, consents or authorizations. The Fund has been advised that no trustees or executive officer of the Fund intends to tender Fund Shares pursuant to the Offer. The Offer does not, however, restrict the purchase of Fund Shares pursuant to the Offer from any such person.
After receiving the Board’s approval on April 15, 2026, the Adviser and the Fund entered into an agreement with Saba pursuant to which the Fund agreed to, among other things, conduct the Tender Offer, and Saba agreed to, among other things, refrain from activist activities with respect to the Fund through at least the conclusion of the 2027 shareholder meeting.
15
| 11. | Certain Legal Matters; Regulatory Approvals. |
The Fund is not aware of any approval or other action by any government or governmental, administrative or regulatory authority or agency, domestic or foreign, that would be required for the acquisition or ownership of Shares by the Fund as contemplated herein. Should any such approval or other action be required, the Fund presently contemplates that such approval or other action will be sought. The Fund is unable to predict whether it may determine that it is required to delay the acceptance for payment of, or payment for, Shares tendered pursuant to the Offer pending the outcome of any such matter. There can be no assurance that any such approval or other action, if needed, would be obtained, or would be obtained without substantial conditions or that the failure to obtain any such approval or other action might not result in adverse consequences to the Fund’s business. The Fund’s obligations under the Offer to accept for payment and pay for Shares are subject to certain conditions described in Section 12.
| 12. | Certain Conditions of the Offer. |
Notwithstanding any other provision of the Offer, the Fund shall not be required to accept for payment or pay for any Shares, may postpone the acceptance for payment of, or payment for, tendered Shares, and may, in its reasonable discretion, terminate or amend the Offer as to any Shares not then paid for if (1) such transactions, if consummated, would (a) result in delisting of the Fund’s common shares from the NYSE or (b) impair the Fund’s status as a regulated investment company under the Code (which would make the Fund subject to U.S. federal income taxes on all of its income and gains in addition to the taxation of Shareholders who receive distributions from the Fund); (2) the amount of Shares tendered would require liquidation of such a substantial portion of the Fund’s securities that the Fund would not be able to liquidate portfolio securities in an orderly manner in light of the existing market conditions, and such liquidation would have an adverse effect on the NAV of the Fund to the detriment of non-tendering Shareholders; (3) there is any (a) in the Board’s judgment, material legal action or proceeding instituted or threatened challenging such transactions or otherwise materially adversely affecting the Fund, (b) suspension of or limitation on prices for trading securities generally on the NYSE or other national securities exchange(s), or the NASDAQ Global Market System, (c) declaration of a banking moratorium by federal or state authorities or any suspension of payment by banks in the United States or New York State, (d) limitation affecting the Fund or the issuers of its portfolio securities imposed by federal or state authorities on the extension of credit by lending institutions, (e) commencement of war, armed hostilities or other international or national calamity directly or indirectly involving the United States or any foreign country in which the Fund invests or which is material to the Fund, or (f) in the Board’s judgment, other event or condition which would have a material adverse effect on the Fund or its Shareholders if tendered Shares were purchased; or (4) determination by the Board that effecting any such transaction would constitute a breach of their fiduciary duty owed to the Fund or its Shareholders.
The foregoing conditions are for the sole benefit of the Fund and may be asserted by the Fund regardless of the circumstances (including any action or inaction by the Fund) giving rise to any such conditions or may be waived by the Fund in whole or in part at any time and from time to time in its sole discretion. The failure by the Fund at any time to exercise any of the foregoing rights shall not be deemed a waiver of any such right, and each such right shall be deemed an ongoing right which may be asserted at any time and from time to time. Any determination by the Fund concerning the events described in this Section shall be final and binding on all parties.
A public announcement shall be made of a material change in, or waiver of, such conditions, and the Offer may, in certain circumstances, be extended in connection with any such change or waiver.
If the Offer is suspended or postponed, the Fund will provide notice to Shareholders of such suspension or postponement.
16
| 13. | Fees and Expenses. |
The Fund will pay all fees and expenses associated with the Offer. The Fund will not pay any broker or dealer, commercial bank, trust company or other person any solicitation fee for any Shares purchased pursuant to the Offer. The Fund will reimburse such persons for customary handling and mailing expenses incurred in forwarding the Offer. No such broker, dealer, commercial bank or trust company has been authorized to act as the agent of the Fund or the Depositary for purposes of the Offer.
The Fund has retained Computershare Trust Company, N.A. to act as Depositary and Georgeson LLC to act as Information Agent. The Depositary and the Information Agent will each receive reasonable and customary compensation for their services and will also be reimbursed for certain out-of-pocket expenses, and the Information Agent will be indemnified against certain liabilities by the Fund.
| 14. | Miscellaneous. |
The Offer is not being made to (nor will tenders be accepted from or on behalf of) holders of Shares in any jurisdiction in which making the Offer or the acceptance thereof would not be in compliance with the laws of such jurisdiction. The Fund may, in its sole discretion, take such action as it may deem necessary to make the Offer in any such jurisdiction.
The Fund is not aware of any jurisdiction in which the making of the Offer or the acceptance of Shares in connection therewith would not be in compliance with the laws of such jurisdiction. Consequently, the Offer is currently being made to all holders of Shares. However, the Fund reserves the right to exclude Shareholders in any jurisdiction in which it is asserted that the Offer cannot lawfully be made. So long as the Fund makes a good faith effort to comply with any state law deemed applicable to the Offer, the Fund believes that the exclusion of Shareholders residing in such jurisdiction is permitted under Rule 13e-4(f)(9) promulgated under the Exchange Act.
| 15. | Contacting the Depositary and the Information Agent. |
The Letter of Transmittal, certificates for the Shares and any other required documents should be sent by each Shareholder of the Fund or his or her broker-dealer, commercial bank, trust company or other nominee to the Depositary as set forth below.
17
The Depositary for the Offer is:
By First Class Mail:
Computershare Trust Company, N.A.
C/O Voluntary Corporate Actions, COY:NFJ
P.O. Box 43011
Providence, RI 02940-3011
By All Trackable and Overnight Mail:
Computershare Trust Company, N.A.
C/O Voluntary Corporate Actions, COY:NFJ
150 Royall Street, Suite V
Canton, MA 02021
Any questions or requests for assistance or additional copies of the Offer, the Letter of Transmittal, the Notice of Guaranteed Delivery, and other documents may be directed to the Information Agent at its telephone number and location listed below. Shareholders may also contact their broker, dealer, commercial bank or trust company or other nominee for assistance concerning the Offer.
The Information Agent for the Offer is:
51 West 52nd Street, 6th Floor
New York, NY 10104
866-989-3459 (toll free)
Notice of Guaranteed Delivery may be sent via email to:
canoticeofguarantee@computershare.com
VIRTUS DIVIDEND, INTEREST & PREMIUM STRATEGY FUND
September 1, 2026
|
|
Computershare Trust Company, N.A. 150 Royall Street, Suite V Canton, MA 02021 Within USA, US territories & Canada 866-270-7788 Outside USA, US territories & Canada 413-775-6091 www.computershare.com |
|
|
LETTER OF TRANSMITTAL TO TENDER SHARES OF VIRTUS DIVIDEND, INTEREST & PREMIUM STRATEGY FUND
|
Pursuant to Virtus Dividend, Interest & Premium Strategy Fund’s (the “Fund”) Issuer Tender Offer Statement dated September 1, 2026, the Fund has offered to purchase up to 25% of its outstanding shares of common stock, or 23,241,811 shares in the aggregate, at a price equal to 99% of the net asset value per share (the “Offer”) as of the close of regular trading on the New York Stock Exchange on October 5, 2026, unless extended (the “Expiration Date”). See Instructions on the reverse side.
I/we, the undersigned, hereby surrender to you for tendering the share(s) identified below. I/we hereby agree to the terms and conditions of the Offer dated September 1, 2026. I/we hereby certify and warrant that: (i) I/we have received and read the Issuer Tender Offer Statement (ii) I/we have complied with all instructions on the reverse side of this Letter of Transmittal and the requirements of the Offer; (iii) I/we have full authority to surrender these certificate(s) and give the instructions in this Letter of Transmittal; and (iv) the shares represented by these certificates are free and clear of all liens, restrictions, adverse claims and encumbrances.
If you hold certificated shares and you wish to participate in the Offer with respect to such certificated shares, you will need to first surrender and exchange your certificated shares for non-certificated shares. Any certificated shares not surrendered in exchange for non-certificated shares prior to the Expiration Date will not be able to participate in the Offer.
If all shares in the Dividend Reinvestment Plan are elected to be tendered, the dividend election will terminate and dividends will be paid in cash per the terms of the Dividend Reinvestment Plan. If after the Offer you continue to have common shares registered in your name with the Computershare, the Fund’s transfer agent (the “Agent”), you may re-enroll in the Dividend Reinvestment Plan at any time by notifying the Agent online at www.computershare.com/investor, or by writing to the Agent at P.O. Box 43078, Providence, RI 02940-3078, or by calling 866-270-7788.
|
|
Signature: This form must be signed by the registered holder(s) exactly as their name(s) appears on the Fund’s share register or by person(s) authorized to sign on behalf of the registered holder(s) by documents transmitted herewith. | |||||||||
|
|
X |
| ||||||||
| Signature of Shareholder |
Date | Daytime Telephone # | ||||||||
| X |
||||||||||
| Signature of Shareholder |
Date | Daytime Telephone # | ||||||||
|
PLACE AN ☐ IN ONE BOX ONLY See instruction number 2 and 3 on the reverse side of this form. | ||||||||||
|
|
☐ Tender All |
or |
|
☐ Partial Tender |
||||||
|
| ||||||||||
| WHOLE SHARES FRACTIONS | ||||||||||
Please complete the back if you would like to transfer ownership or request special mailing.
VOLUNTARY CORPORATE ACTION, COY - NFJF
|
|
E X O T P |
|
04BP0G
|
|
Special Transfer Instruction Please see Instruction number 5 below. |
|
Special Mailing Instruction Please see Instruction number 5 below. |
| ||||||||||
| If you want your shares not accepted for payment and/or check for cash to be issued in another name, fill in this section with the information for the new account/payee name.
Name (Please Print First, Middle & Last Name)
Address (Number and Street)
(City, State & Zip Code)
(Tax Identification or Social Security Number) |
|
Signature Guarantee Medallion
(Title of Officer Signing this Guarantee)
(Name of Guarantor - Please Print)
(Address of Guarantor Firm)
|
|
Fill in ONLY if you want your shares not accepted for payment and/or check for cash to be mailed to someone other than the registered holder or to the registered holder at an address other than that shown on the front of this Letter of Transmittal.
Name (Please Print First, Middle & Last Name)
Address (Number and Street)
(City, State & Zip Code) |
||||||||||
INSTRUCTIONS FOR COMPLETING THE LETTER OF TRANSMITTAL
| 1. | Sign, date and include your daytime telephone number in this Transmittal form in Box 1. After completing all other applicable sections, return this Letter of Transmittal and your original stock certificates in the enclosed envelope. The method of delivery of any documents, including share certificates, is at the election and risk of the tendering shareholder. If documents are sent by mail, it is recommended that they be sent by registered mail, properly insured, with return receipt requested. |
| 2. | If you are tendering all your shares for cash, please check this box only. |
| 3. | If you are tendering some of your shares for cash, please check the box, indicate the number of shares you wish to tender and receive in cash. |
| 4. | If you would like to receive a payment in a currency other than US Dollars please complete box 4 and the attached International Currency Exchange Registration Form. |
| 5. | If you want your check for cash to be issued in another name, fill in Box 4. Signature(s) in Box 4 must be medallion guaranteed. |
| 6. | Complete Box 5 only if your check for cash is to be delivered to a person other than the registered holder or to the registered holder at a different address. |
Form W-9: Under U.S. Federal Income Tax law, a stockholder is required to provide Computershare with such stockholder’s correct Taxpayer Identification Number. If your Taxpayer Identification Number is not certified on our records, we have enclosed a Form W-9 for you to complete and return. Failure to provide the information on the form may subject you to backup withholding on any reportable payment. If you are a foreign individual seeking to qualify as an exempt recipient from backup withholding, you must complete and submit the enclosed Form W-8BEN to Computershare.
| The Information Agent for the Offer is: |
The Depositary for the Offer is: | |||
|
|
| |||
| Georgeson |
By Mail: |
By Registered, Certified or Express Mail | ||
| 51 West 52nd Street, 6th Floor |
Computershare Trust Company, N.A. |
or Overnight Courier: | ||
| New York, NY 10019 |
c/o Voluntary Corporate Actions COY NFJF |
Computershare Trust Company, N.A. | ||
| 866-989-3459 (Toll Free) |
P.O. Box 43011 |
c/o Voluntary Corporate Actions COY NFJF | ||
| Providence, RI 02940-3011 |
150 Royall Street, Suite V | |||
| Canton, MA 02021 | ||||
Offer by
VIRTUS DIVIDEND, INTEREST & PREMIUM STRATEGY FUND
To Purchase for Cash
up to 25% of the Fund’s Outstanding Common Shares
at 99% Net Asset Value
|
THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT
5:00 P.M. EASTERN TIME OCTOBER 5, 2026
|
THIS OFFER IS NOT CONDITIONED ON ANY MINIMUM NUMBER OF SHARES BEING
TENDERED BUT IS SUBJECT TO OTHER CONDITIONS AS OUTLINED IN THE FUND’S
ISSUER TENDER OFFER STATEMENT AND IN THE LETTER OF TRANSMITTAL.
September 1, 2026
To Brokers, Dealers, Commercial Banks,
Trust Companies and Other Nominees:
We are enclosing herewith the material listed below relating to the offer of Virtus Dividend, Interest & Premium Strategy Fund, a Massachusetts business trust registered under the Investment Company Act of 1940, as amended, as a closed end, diversified management investment company (the “Fund”), to purchase up to 25% of the Fund’s outstanding common shares (the “Shares”) upon the terms and conditions set forth in its September 1, 2026 Issuer Tender Offer Statement and related Letter of Transmittal (which together constitute the “Offer”). The Offer will expire at 5:00 p.m. Eastern Time October 5, 2026, or such later date to which the Offer is extended (the “Expiration Date”). The price to be paid for the Shares is an amount per Share, net to the seller in cash, equal to 99% of the net asset value per Share as determined by the Fund at the close of regular trading on the New York Stock Exchange (“NYSE”) on the Expiration Date, or if the Offer is extended, at the close of regular trading on the NYSE on the day the extended Offer expires.
We are asking you to contact your clients for whom you hold Shares registered in your name (or in the name of your nominee) or who hold Shares registered in their own names. Please bring the Offer to their attention as promptly as possible. No fees or commission will be payable to the Fund in connection with the Offer. However, brokers, dealers or other persons may charge shareholders a fee for soliciting tenders for Shares pursuant to the Offer. The Fund will also, upon request, reimburse you for reasonable and customary mailing and handling expenses incurred by you in forwarding any of the enclosed materials to your clients. To the extent applicable, the Fund will pay all transfer taxes on its purchase of Shares; however, shareholders may be obligated to pay transfer taxes on the purchase of Shares by the Fund and other transaction costs in certain circumstances. Backup withholding at a 24% rate may be required unless either an exemption is provided or the required taxpayer identification information and certifications are provided. See Section 8, “Federal Income Tax Consequences of the Offer,” of the Issuer Tender Offer Statement.
Please furnish copies of the following enclosed materials to those of your clients for whose accounts you hold shares in your name or in the name of your securities intermediary:
| 1. | A letter to shareholders of the Fund dated September 1, 2026; |
| 2. | The Issuer Tender Offer Statement dated September 1, 2026; and |
| 3. | Form of letter to clients that may be sent to your clients for whose accounts you hold Shares registered in your name (or in the name of your nominee). |
The Offer is not being made to, nor will the Fund accept tenders from or on behalf of, holders of Shares in any jurisdiction in which the making or acceptance of the Offer would not be in compliance with applicable law.
As described in the Fund’s Issuer Tender Offer Statement under Section 3, “Procedure for Tendering Shares,” tenders may be made without the concurrent deposit of Shares if (1) such tenders are made by or through a broker or dealer that is a member firm of a registered national securities exchange or a member of the Financial Industry Regulatory Authority or a commercial bank or trust company having an office, branch, or agency in the United States; and (2) Computershare Trust Company, N.A. (the “Depositary”) receives, prior to the Expiration Date, a properly completed and duly executed Notice of Guaranteed Delivery substantially in the form provided by the Fund, and (3) confirmation of the delivery of Shares delivered into the Depositary’s account in accordance with the Book-Entry Transfer Facility’s (as defined in the Letter of Transmittal) procedure for such transfer, together with a properly completed and duly executed Letter of Transmittal and any other documents required by the Letter of Transmittal, are received by the Depositary within one business day after the Expiration Date.
As noted in the Offer, this tender offer will not have any special pro-ration provision for odd-lot tenders, which means that all odd-lot tenders (including shareholders who own fewer than 100 Shares) are subject to pro-ration.
Neither the Fund nor its Board of Trustees makes any recommendation to any shareholder as to whether to tender or not tender any Shares.
For additional information or copies of the enclosed material, please contact Georgeson LLC, the Fund’s information agent, at 866-989-3459.
Very truly yours,
Kathryn L. Santoro
Secretary
September 1, 2026
NOTHING CONTAINED HEREIN OR IN THE ENCLOSED DOCUMENTS SHALL CONVEY THE AUTHORITY TO YOU OR ANY OTHER PERSON TO ACT AS AGENT OF VIRTUS DIVIDEND, INTEREST & PREMIUM STRATEGY FUND, THE INFORMATION AGENT, OR THE DEPOSITARY, OR AUTHORIZES YOU OR ANY OTHER PERSON TO MAKE ANY STATEMENTS OR USE ANY MATERIAL ON THEIR BEHALF WITH RESPECT TO THE OFFER, OTHER THAN THE MATERIAL ENCLOSED HEREWITH AND THE STATEMENTS SPECIFICALLY SET FORTH IN SUCH MATERIAL.
2
Offer by
VIRTUS DIVIDEND, INTEREST & PREMIUM STRATEGY FUND
To Purchase for Cash
up to 25% of the Fund’s Outstanding Common Shares
at 99% Net Asset Value
|
THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M. EASTERN TIME OCTOBER 5, 2026 |
THIS OFFER IS NOT CONDITIONED ON ANY MINIMUM NUMBER OF SHARES BEING
TENDERED BUT IS SUBJECT TO OTHER CONDITIONS AS OUTLINED IN THE FUND’S
ISSUER TENDER OFFER STATEMENT AND IN THE LETTER OF TRANSMITTAL.
September 1, 2026
To Our Clients:
Enclosed for your consideration is the September 1, 2026 Issuer Tender Offer Statement of Virtus Dividend, Interest & Premium Strategy Fund, a Massachusetts business trust registered under the Investment Company Act of 1940, as amended, as a closed end, diversified management investment company (the “Fund”), and a related Letter of Transmittal (which together constitute the “Offer”), pursuant to which the Fund is offering to purchase up to 25% of the Fund’s outstanding common shares (the “Shares”) upon the terms and conditions set forth in the Offer.
The Issuer Tender Offer Statement is being forwarded to you for your information only and cannot be used by you to tender Shares held by us for your account. We are the holder of record of Shares held for your account. A tender of such Shares can be made only by us as the holder of record and only pursuant to your instructions.
Your attention is called to the following:
| 1. | The purchase price to be paid for the Shares is an amount per Share, net to the seller in cash, equal to 99% of the net asset value per Share as determined by the Fund at the close of regular trading on the New York Stock Exchange (“NYSE”) on October 5, 2026, or if the Offer is extended, at the close of regular trading on the NYSE on the day the extended Offer expires. The current net asset value of the Fund is calculated daily and may be obtained by calling Georgeson LLC, the Fund’s information agent, toll free at 866-989-3459 or by calling the Fund toll free at 866-270-7788. |
| 2. | The Offer is not conditioned upon any minimum number of Shares being tendered. |
| 3. | Upon the terms and subject to the conditions of the Offer, the Fund will purchase all Shares validly tendered on or prior to 5:00 p.m. Eastern Time on October 5, 2026, or such later date to which the Offer is extended (the “Expiration Date”). |
| 4. | No fees or commission will be payable to the Fund in connection with the Offer. However, tendering shareholders may be obligated to pay brokerage commissions or share transfer taxes on the purchase of Shares by the Fund pursuant to the Offer. |
| 5. | Your instructions to us should be forwarded in ample time before the Expiration Date to permit us to submit a tender on your behalf. |
YOUR INSTRUCTIONS TO US SHOULD BE FORWARDED AS PROMPTLY AS POSSIBLE IN ORDER TO PERMIT US TO SUBMIT A TENDER ON YOUR BEHALF IN ACCORDANCE WITH THE TERMS AND CONDITIONS OF THE OFFER.
The Offer is not being made to, nor will tenders be accepted from or on behalf of, holders of Shares in any jurisdiction in which the making or acceptance of the Offer would not be in compliance with applicable law.
Neither the Fund nor its Board of Trustees is making any recommendation to any shareholder whether to tender or refrain from tendering Shares in the Offer. Each shareholder is urged to read and evaluate the Offer and accompanying materials carefully.
INSTRUCTIONS
The undersigned acknowledge(s) receipt of the Virtus Dividend, Interest & Premium Strategy Fund’s (the “Fund”) letter and the enclosed Issuer Tender Offer Statement and the Letter of Transmittal dated September 1, 2026, relating to the Fund’s offer to purchase up to 25% of the Fund’s outstanding shares as of October 5, 2026 (or such later date should the Fund’s offer be extended) (the “Offer”).
This will instruct you to tender to the Fund the number of shares indicated below (which are held by you for the account of the undersigned), upon the terms and subject to the conditions set forth in the Offer that you have furnished to the undersigned.
AGGREGATE NUMBER OF SHARES TO BE TENDERED:
Shares
ENTER NUMBER OF SHARES TO BE TENDERED.
| PLEASE SIGN HERE: |
| Dated: , 2026 | ||
| Name(s): |
||||||
| Address: |
||||||
|
|
City: |
State: | Zip Code: |
|
| Area Code and Telephone Number: |
|
|||||||||
| Account Number or Social Security Number: |
| |||||||||
2
Virtus Dividend, Interest & Premium Strategy Fund
c/o Virtus Investment Advisers, LLC
One Financial Plaza
Hartford, CT 06103
Dear Shareholder:
On April 15, 2026, the Board of Trustees (the “Board”) of Virtus Dividend, Interest & Premium Strategy Fund (the “Fund”) considered and voted in favor of a proposal to conduct a tender offer for up to 25% of the Fund’s outstanding common shares, $0.00001 par value (the “Shares”) for cash at a price equal to 99% of the Fund’s net asset value per share (“NAV”).
As a result, the Fund is hereby commencing an offer to purchase up to 25% of the Fund’s outstanding Shares for cash at a price equal to 99% of the Fund’s NAV per Share as of the close of regular trading on the New York Stock Exchange (“NYSE”) on October 5, 2026 (or, if the tender offer is extended, as of the close of regular trading on the NYSE on the day the extended tender offer expires), upon the terms and conditions set forth in the enclosed Issuer Tender Offer Statement and the related Letter of Transmittal (which together constitute the “Offer”).
The Offer is intended to provide tendering shareholders with a monetary benefit to the extent that the tender price is above the trading price of the Fund’s Shares. The deadline for participating in the Offer is 5:00 p.m. Eastern Time October 5, 2026, or such later date through which the Offer is extended.
It is contemplated, subject to change, that payment for tendered Shares, if accepted for payment, will be made on or about October 13, 2026 for shareholders holding Shares through a broker, dealer, commercial bank, trust company or other nominee, and October 13, 2026 for shareholders holding Shares directly.
If, after carefully evaluating all information set forth in the Offer, you wish to tender Shares pursuant to the Offer, please either follow the instructions contained in the Offer or, if your Shares are held of record in the name of a broker, dealer, commercial bank, trust company or other nominee, contact such firm to effect the tender for you. Shareholders are urged to consult their own investment and tax advisers and make their own decisions whether to tender any Shares.
As of July 31, 2026, the Fund’s NAV per Share was $16.40 and 92,967,244 Shares were issued and outstanding. The Fund’s NAV during the pendency of the Offer may be obtained by contacting Georgeson LLC, the Fund’s information agent, toll free at 866-989-3459 between 9:00 a.m. and 11:00 p.m. Eastern Time, Monday through Friday, or by calling the Fund toll free at 866-270-7788 between 8:30 a.m. and 6:00 p.m. Eastern Time, Monday through Thursday, and 8:30 a.m. and 5:00 p.m. Eastern Time on Friday (except holidays).
Neither the Fund nor its Board is making any recommendation to any shareholder whether to tender or refrain from tendering Shares in the Offer. The Fund and the Board urge each shareholder to read and evaluate the Offer and related materials carefully and make their own decision. Questions, requests for assistance and requests for additional copies of this Offer and related material should be directed to Georgeson at 866-989-3459.
Very truly yours,
Kathryn L. Santoro
Secretary
September 1, 2026
|
|
News Release
|
Virtus Dividend, Interest & Premium Strategy Fund
Announces Tender Offer
HARTFORD, CT, April 17, 2026 – Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ) (the “Fund”) today announced that its Board of Trustees has approved a tender offer (“Tender Offer”) intended to enhance shareholder value, provide shareholders with an additional source of liquidity for their investment, and provide the potential to reduce the Fund’s trading discount to its net asset value per share (“NAV”). Pursuant to the terms of the Tender Offer, the Fund will offer to purchase for cash up to 25% of the Fund’s outstanding common shares at a price per share equal to 99.0% of the Fund’s NAV determined following the expiration of the Tender Offer. The Tender Offer is expected to commence on or about September 1, 2026.
The Tender Offer is being proposed pursuant to an agreement with Saba Capital Management, L.P. (“Saba”) that will expire after the Fund’s 2028 proxy season. During the effective period of the Agreement, Saba has agreed to certain standstill provisions and voting commitments.
The above statements are not intended to constitute an offer to participate in any tender offer. Additional terms and conditions of the Tender Offer will be included in the Fund’s offering materials, which will be distributed to the Fund’s shareholders and filed with the Securities and Exchange Commission. Shareholders are encouraged to review those materials carefully when they become available.
About the Fund
Virtus Dividend, Interest & Premium Strategy Fund is a diversified closed-end fund that seeks current income and gains, with long-term capital appreciation as a secondary objective. The Fund generally invests approximately 75% of its total assets in equity securities and approximately 25% in convertible securities and employs an option strategy of writing covered call options on a portion of its portfolio. Virtus Investment Advisers, LLC (“VIA”), is the investment adviser to the Fund, and NFJ Investment Group, an affiliate of VIA, and Voya Investment Management are its subadvisers. For more information on the Fund, contact shareholder services at (866) 270-7788, by email at closedendfunds@virtus.com, or through the Closed-End Funds section of virtus.com.
Fund Risks
An investment in a fund is subject to risk, including the risk of possible loss of principal. A fund’s shares may be worth less upon their sale than what an investor paid for them. Shares of closed-end funds may trade at a premium or discount to their net asset value. For more information about the Fund’s investment objective and risks, please see the Fund’s annual report. A copy of the Fund’s most recent annual report can be accessed through the Closed-End Funds section of virtus.com and may be obtained free of charge by contacting “Shareholder Services” as set forth at the end of this press release.
# # #
Statements in this press release that are not historical facts are forward-looking statements as defined by the United States securities laws. Forward-looking statements speak only as of the date they are made, and the Fund assumes no duty to and does not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements, and future results could differ materially from historical performance.
This press release does not constitute a recommendation, an offer to purchase, or an offer to sell or a solicitation to buy, nor shall there be any sale of shares in the Fund in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction.
For Further Information:
Shareholder Services
(866) 270-7788
closedendfunds@virtus.com
NOTICE OF GUARANTEED DELIVERY
FOR
TENDER OF COMMON SHARES OF
VIRTUS DIVIDEND, INTEREST & PREMIUM STRATEGY FUND
This form, or one substantially equivalent hereto, must be used to accept the Offer (as defined below) if a shareholder’s certificates for common shares (the “Shares”) of Virtus Dividend, Interest & Premium Strategy Fund (the “Fund”) are not immediately available or the Letter of Transmittal and other required documents are not able to be delivered to the Depositary (as defined below) on or before 5:00 p.m. Eastern Time on October 5, 2026, or such later date to which the Offer is extended (the “Expiration Date”). Such form may be delivered by email or mail to the Depositary and must be received by the Depositary on or before the Expiration Date. See Section 3, “Procedure for Tendering Shares,” of the Fund’s Issuer Tender Offer Statement.
The Depositary:
Computershare Trust Company, N.A.
By First Class Mail:
Computershare Trust Company, N.A.
Voluntary Corporate Actions, COY:NFJ
P.O. Box 43011
Providence, RI 02940-3011
By Overnight Courier:
Computershare Trust Company, N.A.
Voluntary Corporate Actions, COY:NFJ
150 Royall Street, Suite V
Canton, MA 02021
Via email:
canoticeofguarantee@computershare.com
Please Note: Only brokers can deliver this Notice of Guarantee via email
DELIVERY OF THIS INSTRUMENT TO AN ADDRESS OTHER THAN AS SET FORTH ABOVE OR TRANSMISSION VIA EMAIL OTHER THAN AS SET FORTH ABOVE DOES NOT CONSTITUTE A VALID DELIVERY
002CSR0B26
Ladies and Gentlemen:
The undersigned hereby tenders to Virtus Dividend, Interest & Premium Strategy Fund (the “Fund”), upon the terms and subject to the conditions set forth in its September 1, 2026 Issuer Tender Offer Statement and related Letter of Transmittal (which together constitute the “Offer”), receipt of which is hereby acknowledged, the number of Shares set forth below pursuant to the guaranteed delivery procedures set forth in Section 3, “Procedure for Tendering Shares,” of the Fund’s Issuer Tender Offer Statement.
Participants tendering their Shares should notify the Depositary prior to covering through the submission of a physical security directly to the Depositary based on a guaranteed delivery that was submitted via DTC’s PTOP platform.
| Number of Shares Tendered: |
|
If Shares will be tendered by book-entry transfer, check box:
☐ The Depository Trust Company
| Account Number: |
| Name(s) of Record Holder(s): |
||
| Address: | ||
| Area Code and Telephone Number: | ||
The undersigned also tenders all uncertificated Shares that may be held in the name of the registered holder(s) by the Fund’s transfer agent pursuant to the Fund’s Automatic Reinvestment and Cash Purchase Plan:
☐ Yes ☐ No (Note: If neither of these boxes is checked, any such uncertificated Shares will not be tendered.)
|
Dated: , 2026 |
| |
|
| ||
| Signature(s) | ||
2
GUARANTEE
The undersigned, a member firm of a registered national securities exchange, a member of the Financial Industry Regulatory Authority, or a commercial bank or trust company having an office, branch, or agency in the United States, hereby (a) guarantees to deliver to the Depositary the Shares tendered hereby, in proper form for transfer (or tender Shares pursuant to the procedure for book-entry transfer) into the Depositary’s account at The Depository Trust Company, together with (i) a properly completed and duly executed Letter of Transmittal with any required signature guarantees and (ii) other required documents, within one business day after the Expiration Date of the Offer, and (b) represents that such tender of Shares complies with Rule 14e-4 under the Securities Exchange Act of 1934, as amended.
| Name of Firm: |
| |||
| (Authorized Signature) | ||||
| Address: | Name: | |||
| (Please Print)
| ||||
|
|
Title: | |||
| City State Zip | ||||
| Area Code and Tel. No. | Dated: , 2026 | |||
3
AGREEMENT
This Agreement (the “Agreement”) is made and entered into effective as of the 17th day of April, 2026 by and among Virtus Investment Advisers, LLC (“Virtus”), a Delaware limited liability company having a place of business at One Financial Plaza, Hartford, CT 06103, Virtus Dividend, Interest & Premium Strategy Fund (the “Fund”) and Saba Capital Management, L.P., a Delaware limited partnership having a place of business at 405 Lexington Avenue, 58th Floor, New York, New York, 10174 (“Saba” and with Virtus and the Fund, each, a “Party,” and collectively the “Parties”).
WHEREAS, Virtus is registered as an investment adviser with the Securities and Exchange Commission under the Investment Advisers Act of 1940, as amended, and acts pursuant to investment advisory contracts as the investment adviser to various registered closed-end management investment companies, including the Fund, a Massachusetts business trust registered under the Investment Company Act of 1940, as amended (the “1940 Act”); and
WHEREAS, any pooled investment vehicles or accounts managed or controlled by Saba or its “affiliated persons” (as that term is defined in the 1940 Act), excluding the Saba RICs, are referred to herein collectively as “Saba Funds”; and
WHEREAS, Saba and the Saba Funds are deemed to be the beneficial owner of common shares of beneficial interest (“Shares”) of the Fund by reason of their power to vote and direct the disposition of such shares held by various related entities; and
WHEREAS, one or more investment companies registered under the 1940 Act managed by Saba (such registered investment companies, the “Saba RICs”) legally own Shares. Notwithstanding anything herein to the contrary, the Saba RICs are not a party to, are not restricted by and are not governed by the terms and provisions of this Agreement and nothing in this Agreement shall restrict Saba from acting on behalf of the Saba RICs in accordance with its duties as investment advisor to the Saba RICs; and
WHEREAS, the Fund has entered into a non-disclosure agreement with Saba dated March 31, 2026, as amended, regarding confidentiality and other obligations with respect to discussions regarding possible courses of action that the Fund could undertake; and
WHEREAS, the Parties to this Agreement wish to resolve matters concerning the Fund and possible courses of action;
NOW, THEREFORE, in consideration of the mutual promises and covenants contained in this Agreement, and for other good and valuable consideration, and without any admission of liability, or inadequacy of claims whatsoever, by any of the Parties, the Parties hereto agree as follows:
| 1. | Virtus Obligations. |
(a)(i) Virtus and the Fund each hereby agrees, based in part upon the recommendation of Virtus and contingent upon Saba’s mutual acceptance of the terms of this Agreement, that the Fund shall commence a cash self-tender offer pursuant to the requirements of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”) to purchase 25% (the “Maximum Amount”) of the then outstanding Shares of the Fund, and all shareholders shall have the opportunity to tender some or all of their Common Shares in such tender offer at a price equal to 99% of the NAV of the Fund’s Shares as determined as of the close of the regular trading session of the New York Stock Exchange on the date the tender offer expires (“Tender Offer”). The Fund will use its best efforts to complete the Tender Offer and pay for the Shares tendered in
such Tender Offer as soon as practicable but no later than October 14, 2026; provided that in no event shall any Tender Offer expire or close prior to October 3, 2026; provided further that the Tender Offer may be extended if required by law; (ii) the Fund shall purchase Shares properly tendered and not withdrawn on a prorated basis up to the Maximum Amount, if greater than the Maximum Amount of Shares are properly tendered and not properly withdrawn; (iii) if less than the Maximum Amount of Shares has been properly tendered and not withdrawn, then the Fund shall only be obligated to purchase such number of Shares actually tendered; (iv) the consideration to be paid by the Fund for Shares purchased under the Tender Offer shall consist solely of cash; and (v) the Fund shall pay for any of the Shares tendered in such Tender Offer no later than the seventh (7th) business day after the expiration or closing of the Tender Offer (such date of payment, the “Tender Offer Payment Date”).
(b) The Tender Offer shall not provide for preferential treatment for any shareholders of the Fund.
(c) Other than in connection with regularly scheduled distributions under a dividend reinvestment plan, the Fund shall not issue any Shares or any securities exchangeable or convertible into Shares prior to the Tender Offer Payment Date.
(d) the Tender Offer shall require odd lot tenders to be subject to the same proration terms as tenders of 100 Common Shares or more.
(e) The Fund shall not effectuate, or propose to shareholders for approval any proposal or plan to effectuate, a redomiciliation to another state or a merger, engage in a rights offering, consolidation or reorganization with or involving another investment company registered under the 1940 Act prior to the Tender Offer Payment Date (whether or not the Fund is the surviving company).
(f) In the event the Fund delays or determines not to commence or complete the Tender Offer, Virtus shall provide Saba with prompt written notice together with a reasonable explanation of the basis for such delay or determination. Following the termination of the delaying event, the Fund shall recommence the Tender Offer as soon as practicable and in no event later than twenty (20) calendar days thereafter.
| 2. | Saba Obligations. During the period from the date of this Agreement through the date that is the earliest of (i) the conclusion of the Fund’s 2028 annual meeting of shareholders or July 15, 2028, whichever is earlier, (ii) such date that the Fund determines not to conduct or to discontinue the Tender Offer and (iii) October 21, 2026, if the Tender Offer Payment Date has not occurred on or prior to that date for any reason (the “Effective Period”), Saba agrees that it shall, and shall cause the Saba Funds to, comply with the following: |
(a) With respect to matters to be presented at any shareholder meetings of the Fund:
(i) Saba and the Saba Funds (except, for the avoidance of doubt, the Saba RICs) shall vote, or shall direct to be voted, all Shares of the Fund over which Saba and the Saba Funds (except, for the avoidance of doubt, the Saba RICs) have discretion or beneficial ownership and entitled to vote as of the applicable record date in accordance with the recommendations of the Fund’s board of trustees (the “Board”);
aa. provided, that doing so would not violate the written proxy voting policy of any client advised by Saba; provided, further, that to the extent such proxy voting policy
2
does not explicitly permit Saba to vote in accordance with the recommendations of the Board but does not explicitly require that it vote against the proposal, Saba agrees to abstain from voting on such matter; Saba agrees that during the term of this Agreement, upon the reasonable written request of Virtus, it will promptly inform Virtus of whether the proxy voting policy of any client advised by Saba requires it to vote in a manner other than in accordance with the recommendations of the Board; and
bb. further provided, that notwithstanding anything to the contrary set forth in Section 2(a)(i)(aa) above, Saba and the Saba Funds (except, for the avoidance of doubt, the Saba RICs) shall vote, or shall direct to be voted, all Shares of the Fund over which Saba and the Saba Funds (except, for the avoidance of doubt, the Saba RICs) have discretion or beneficial ownership and entitled to vote as of the applicable record date in accordance with the Board’s recommendations relating to:
(I). the election of trustees to the Board;
(II). any proposal submitted by a shareholder of the Fund; and
(III). any merger or reorganization involving the Fund.
(ii) Saba and the Saba Funds shall not solicit any proxies with respect to proposals submitted or to be submitted to the Fund’s shareholders, provided, however, that nothing in this Agreement may be interpreted as prohibiting Saba and the Saba Funds from encouraging other shareholders to vote as recommended by the Board;
(iii) Saba and the Saba Funds shall not execute any written consent with respect to the Fund’s Shares other than as may be solicited by the Fund or its Board;
(iv) Saba and the Saba Funds shall not seek to exercise control or influence over the management or policies of the Fund;
(v) Saba and the Saba Funds shall not, directly or indirectly, with respect to the Fund:
(I). propose, or make any filing with respect to, any proposals or matters seeking the vote or consent of shareholders, or any proposals or matters for the consideration of the Board, including, but not limited to, any form of business combination, restructuring, recapitalization, dissolution or similar transaction involving the Fund, including, without limitation, a merger, tender or exchange offer, open-ending, conversion to an exchange traded fund or interval fund, share repurchase or liquidation of the Fund’s assets;
(II). seek the removal of any member of the Board; and
(III). nominate any individuals for election to the Board or otherwise seek appointment to or representation on the Board.
3
(vi) Saba and the Saba Funds shall conform to the following restrictions, with respect to the Fund:
aa. Unless consented to by the Board, Saba and the Saba Funds shall not join any “group” (within the meaning of Section 13(d)(3) of the Exchange Act and Rule 13d 5(b)(1) thereunder) of unaffiliated third parties concerning the Fund; and
bb. Saba and the Saba Funds shall not provide any advice, aid or encouragement that is designed to do indirectly or to urge others, to do things that Saba and the Saba Funds each has agreed not to do in the Agreement with respect to the Fund, including, but not limited to:
i. putting forward shareholder proposals or trustee nominations; or
ii. voting against any matter recommended by the Board.
(b) Saba and the Saba Funds shall not purchase any additional securities issued by the Fund until the Tender Offer Payment Date.
(c) Saba hereby irrevocably withdraws its shareholder proposal purportedly submitted for consideration at the Fund’s 2026 shareholder meeting.
Nothing herein shall be deemed to prohibit Saba and its affiliates from communicating privately with the trustees, officers and advisors of the Fund (including the Advisor) so long as such private communications would not be reasonably determined to trigger public disclosure obligations for any Party. In addition, the covenants set forth in this Section 3.1 shall not be deemed to prevent the voting of any voting securities of the Fund held by a Saba RIC in the same proportion as the vote of all other holders of such security (“Mirror Voting”) in accordance with the proxy voting policy of such Saba RIC or prevent the Saba RICs from taking or failing to take any other action during the Effective Period.
3. Responsibility for Representatives. Each Party shall take all commercially reasonable measures practicable to prevent its present and future officers, directors, partners, employees, representatives and its controlled affiliates from engaging in conduct otherwise prohibited by this Agreement.
4. No Disparagement. For a period from the date hereof through the termination of this Agreement, each Party hereto shall not directly or indirectly disparage, impugn or take any action reasonably likely to damage the reputation of any other Party, their affiliates, their representatives, or any of the members of the Board (in each case, solely with respect to their service to such other Party). The foregoing shall not apply to any compelled testimony or production of information, either by legal process or subpoena or in connection with a response to a request for information from any governmental authority with jurisdiction over the Party from whom information is sought.
5. No Assignment. This Agreement shall be binding upon the Parties and, except as otherwise provided herein, upon their respective legal successors. No Party may assign this Agreement without the prior written consent of each other Party and any such attempted assignment shall be void.
6. Public Statements. The Parties acknowledge and agree that this Agreement will be filed as an exhibit to an amendment to the Schedule 13D, as amended, relating to the Fund filed by Saba and the Saba Funds.
7. No Third-Party Beneficiaries. This Agreement is solely for the benefit of Virtus, the Fund and Saba and is not enforceable by any other persons. None of the parties to this Agreement may assign its rights or delegate its obligations under this Agreement, whether by operation of law or otherwise, without the prior written consent of the other parties hereto, and any assignment in contravention hereof will be null and void.
4
8. Applicable Law. The validity of this Agreement, the construction and enforcement of its terms, and the interpretations of the rights and duties of the Parties shall be governed by the laws of the State of New York, without regard to conflicts-of-law principles.
9. Jurisdiction. The Parties agree that the sole venue for any action brought under this Agreement shall be the United States District Court for the Southern District of New York or, if that court lacks subject matter jurisdiction, any New York state court situated in New York County. The Parties irrevocably and unconditionally waive any objection to the laying of venue of any action, suit or proceeding arising out of this Agreement, or the transactions contemplated hereby, in the United States District Court for the Southern District of New York or any New York state courts situated in New York County, and hereby further irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum.
10. Damages; Injunctive Relief. Each Party shall be entitled to seek specific performance hereunder, including, without limitation, injunctive and other equitable relief to enforce this Agreement without proof of actual damages, in addition to any other remedies as may be available at law or in equity.
11. Modification. No modification, amendment, supplement to or waiver of this Agreement or of any of its provisions shall be binding upon the Parties hereto unless made in writing and duly signed by all Parties.
12. Invalidity. In the event that any one or more of the provisions of this Agreement shall for any reasons be held to be invalid, illegal or unenforceable, the remaining provisions of this Agreement shall be unimpaired, and the invalid, illegal or unenforceable provision or provisions shall be replaced by a mutually acceptable provision, which being valid, legal and enforceable, comes closest to the economic effect and intent of the Parties underlying the invalid, illegal or unenforceable provision or provisions.
13. No Waiver. A waiver or breach of any provision of this Agreement, or a default under this Agreement, shall not be deemed to be a waiver of any other provision of this Agreement or a subsequent breach or default of this Agreement. The failure or delay in enforcing compliance with any term or condition of this Agreement shall not constitute a waiver of such term or condition, unless compliance with such term or condition is expressly waived in writing.
14. Counterparts. This Agreement may be executed in one or more counterparts transmitted by facsimile or other electronic means, and each counterpart shall have the effect of an original.
15. Term and Termination. This Agreement shall remain in effect until the earliest of the following:
(a) the last day of the Effective Period;
(b) such other date as the Parties may agree in writing;
(c) the tenth (10th) business day after written notice by Saba to the Fund advising of a material breach of this Agreement by the Fund, if such breach has not been cured or remedied on or prior to such day; provided, however, that Saba is not in material breach of this Agreement at the time such notice is given; and
5
(d) the tenth (10th) business day after written notice by the Fund to Saba advising of a material breach of this Agreement by Saba, if such breach has not been cured or remedied on or prior to such day; provided, however, that the Fund is not in material breach of this Agreement at the time such notice is given.
16. Notices. Unless otherwise provided herein, all notices called for by this Agreement shall be given in writing, including by electronic mail. Until notice is given to the contrary in accordance with this Paragraph 16, all notices to the respective Parties shall be directed to:
If to Virtus or the Fund:
Attention: Andra Purkalitis, EVP and General Counsel
Virtus Investment Advisers, LLC
One Financial Plaza, 26th Floor
Hartford, CT 06103
Telephone: (860) 263-4784
Email: andra.purkalitis@virtus.com
If to Saba or the Saba Funds:
Attention: Michael D’Angelo
Saba Capital Management, L.P.
405 Lexington Avenue, 58th Floor
New York, New York 10174
Email: Michael. D’Angelo@sabacapital.com
17. Entire Agreement. This Agreement, together with any written agreement entered into by the Parties on or after the date of this Agreement, shall constitute the entire Agreement among the Parties and shall supersede all previous agreements, promises, proposals, representations, understandings and negotiations, whether written or oral, among the Parties respecting the subject matter hereof.
[Signature Page Follows]
6
IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first above written.
Virtus Investment Advisers, LLC
| By: |
| |
| Name: |
Richard W. Smirl | |
| Title: | Executive Vice President |
Virtus Dividend, Interest & Premium Strategy Fund
| By: |
| |
| Name: | Richard W. Smirl | |
| Title: |
Executive Vice President | |
Saba Capital Management, L.P.
| By: |
| |
| Name: |
Michael D’Angelo | |
| Title: |
Chief Operating Officer and General Counsel |
7